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ABSTRACT

Sexual dimorphism of the central nervous system is a still widely debated and an area
of much research. Conclusive evidence that anatomical and physiological differences
in the CNS exist has been reported by post-mortem studies and magnetic resonance
imaging (MRI). This present study seeks to contribute to the understanding of the
differences in the brain between genders and to ascertain reasons as to why the
literature is so varied.

A number of structures such as the cerebral cortex, hypothalamic nuclei and the
amygdala have proven to be significantly larger within males as opposed to females.
The nuclei of the hypothalamus and the amygdala are involved in a variety of
functions all closely related to sexual behaviour. The increase in size of these
structures within males may contribute to the increase in psychosexual disorders seen
more commonly in males. The anterior commissure and corpus callosum, two grey
matter structures, have been shown to be larger in females, enabling females to utilise
both hemispheres of the cerebrum when unde1iaking certain tasks, whereas males are
seen to use one hemisphere.

It is known that ce1iain diseases and disorders are more common or appear more
severe in one sex compared to the other. Con-elations have been found linking disease
prevalence and severity with androgens, yet few have reported relationships between
brain structure and disease. Neuropsychological disorders such as autism and
schizophrenia have been linked to the anatomical differences of the male and female
brain, however the pathology of the majority of sexually dimorphic diseases remains
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largely unknown. Experimental designs need to be reassessed in order to provide
significant evidence of sexual dimorphism in these pathologies. Sex must be seen as
an important variable that needs to be accounted for in order to contribute to the
understanding of the functional differences exhibited by males and females.
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AIM OF STUDY

The overall aim of this present study was to critically review gender specific
contempormy research into the anatomical and physiological differences in the central
nervous system and to ascertain their relationship to disease.
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CHAPTER ONE

Introduction

Since the 1950's, scientists have sought to produce conclusive evidence supporting
the theory that anatomical and physiological differences exist within the central
nervous system between genders. Evidence has been collected throughout this period
in support of this theory, through the use of laboratory animals and the study of
hormonal abnormalities within humans (Good et al, 2001).

The development of the human brain in childhood and adolescence is characterised by
progressive and regressive processes that determine the size and shape of a particular
brain structure. In vivo studies using magnetic resonance imaging (MRI) have
provided some of the answers that are sought in regards to sexual dimorphism of the
brain. MRI studies have enabled researchers to conduct large sample studies on the
human brain, providing information that small scale post mortem studies are unable to
provide (Good et al, 2001).

The development of two individual sexes within a species is a common trait
throughout the animal kingdom and is referred to as sexual dimorphism. Genes and
their interaction with specific sex hormones play a pivotal role in determining the
gender of an individual (Kalthoff, 2001). Developmental biologists have been able to
identify the genetic pathways that control sex determination within many species such
as Drosophila melanogaster (fruit fly) and Caenorhabditis elegans (roundworm), yet
identifying the same in mammalian development has proved to be more difficult
(Goodfellow and Lovell-Badge, 1993).
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All female oocytes carry the X chromosome so it is the males' spermatozoa that
contributes either an X or Y chromosome and thus determines the sex of an embryo.
A normal human male embryo has an XY genotype whilst female embryos' consist of
an XX genotype. The Y chromosome can therefore be seen as the critical factor for
male sex differentiation (Kalthoff, 2001).

A region on the Y chromosome named the testis-determining factor (TDF), which
spans :}5kb, has been determined as the region that codes for testis formation. An
impmiant gene named the sex-determining region Y (SRY) has been located within
the TDF and has been linked with the first stage of sexual differentiation. The SRY
gene has a crucial role within the testes where developing Sertoli cells that will
differentiate, nourish and protect spermatogonia (stem cells that differentiate into
spermatozoa) are formed. Due to the lack of the Y chromosome, female gonadal
ridges differentiate into ovarian cells (Johnson and Everitt, 2000).
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CHAPTER TWO

Sex Determination and the SRY Gene

The formation of testes occurs due to the presence of the SRY gene located on the Y
chromosome. SRY expression occurs within the pre-Sertoli cells that are located
within the male genital ridge of a developing embryo. The SRY protein structure
provides the only clue as to how this gene encodes testis fom1ation. It is composed of
a single exon with a DNA binding high mobility group (HMG) box and therefore is a
transcription factor with the ability to alter other genes in the sex determination
pathway. The HMG box allows the SRY protein to bind to the minor groove within
DNA, causing the DNA to bend and expose certain binding sites to other proteins that
may be necessary in the developmental pathway (Viger et al, 2005). The majority of
SRY mutations that occur within humans are located within the HMG box which
emphasises the importance of the gene, yet the exact mechanism that causes SRY to
act as a testis-determining factor still remains unclear (Harley et al, 2003).

The first evidence of the mouse SRY gene (Sry) occurs at day 10.5 of embryo
development and rises to peak levels at day 11.5. By day 14.5 of embryo genesis the
S1y protein is no longer detected as the Sry expression abruptly halts. Within humans,
the SRY protein can be detected between day 41 and 45 postovulation and can still be
present at day 52. Unlike S1y in the mouse, human expression of SRY is not abruptly
stopped and is located within the genital ridge and to a minor extent in the brain
(Viger et al, 2005).
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Experimental studies have shown that the S1y exerts its action on the supporting cell
lineage of the developing gonad to direct the differentiation of Sertoli cells rather than
the default female follicular cells. Yet Sry is not always necessmy for Sertoli cell
differentiation as knockout mice (mice with the Sry gene deleted) have been seen to
produce Sertoli cells even without the Sry gene. These studies suggest that the SRY
gene is just one of the genes involved in male sex determination (Goodfellow and
Lovell-Badge, 1993).

The study of human XX sex reversal and the use of transgenic mice have been
valuable in trying to ascertain how SRY expression is controlled. These studies have
suggested that there are transactivating factors within the male and female genital
ridge that recognises the SRY promoter and can express the SRY gene. Evidence
suggests that these factors are SOX9, SF-1, WT1, DMRT1, GATA4 and DAX-1
(Viger et al, 2005).

2.1 Other Genes Involved in Sex Determination
2.1.1 SOX9

The SOX family of genes share the same homology with the HMG box of the SRY
gene. Like the SRY gene, the HMG box enables SOX9 to act as a transcription factor
and is able to bind and bend specific DNA sequences. A mutation in the SOX9 gene is
responsible for causing Campomelic Dysplasia, a male to female sex reversal disease
associated with skeletal malformations and XY gonadal dysgenesis in 75% of
individuals. This gene has proven to be
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important sex determining gene due to its

high conservation amongst vertebrates and the fact that the gene causes sex reversal
when mutated. SOX9 is expressed within bone of both sexes and within the testis of
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males which explains the phenotypic effects of this gene when it becomes mutated.
(Knower et al, 2003).

The SOX9 protein is located within the cytoplasm of the undifferentiated gonad in
both sexes (Gasca et al, 2002). Yet soon after the expression of SRY, SOX9 expression
is upregulated within the male urogenital ridge and downregulated within the
females'. SOX9 upregulation within the male causes movement of the protein into the
Sertoli ,cell nucleus from the cytoplasm. It is believed that this movement of the
protein is possible through two nuclear localisation signals (NLS) located in the HMG
box allowing the shuttling of SOX9 from the cytoplasm into the nucleus as sexual
differentiation occurs. Once SOX9 has been shuttled into the nucleus it is then able to
activate other genes in the sex differentiation pathway. Once the necessary genes have
been activated SOX9 is exported out of the nucleus and back into the cytoplasm
through the nucleus export signal (NES), also located in the HMG box (Knower et al,
2003).

The expression of SOX9 within the nucleus appears to be all that is required to ensure
sexual differentiation of the male gonad. When leptomycin B, an inhibitor of nuclear
export signals, is cultured in female gonads the result is the formation of male gonads.
This suggests that SOX9 does not have to be exported out of the nucleus for male sex
differentiation to occur. Female transgenic mice expressing Sox9 have been shown to
produce normally functioning Sertoli cells and Leydig cells which suggests Sry is not
necessary for male sexual differentiation but rather is expressed to upregulate Sox9
expression. Therefore SOX9 is most likely the next sex determining gene after SRY in
the sex determination pathway (Knower et al, 2003).

5

The targets of SOX9 in the sex determination pathway have been discovered using
both in vitro and in vivo studies. Two genes, Steroidogenic Factor-1 (SF-1) and
Mullerian Inhibiting Hormone (MIH) have been shown to be transactivated by the
Sox9 protein and are also expressed within the gonad (Knower et al, 2003).

2.1.2 SF-1

SF-1 (steroidogenic factor 1) is an orphan nuclear receptor due to its unknown
activatip.g ligand and is expressed within the gonads and adrenal glands of both sexes,
controlling the transcription of genes that are involved in steroidogenesis (Swain et al,
1999). Both the gonads and adrenal glands derive from the adrenogenital primordium
(AGP) which is observable at day 9 of embryogenesis (E9) within the mouse. By El3
the gonads and adrenals have separated from one another and are clearly visible as
distinct organs. The gonads have differentiated into either ovaries or testes by E12 and
by E 16 the adrenal glands have formed the cortex, medulla and functional zone of the
organ (Valet al, 2003).

The expression of Sf-1 (mouse SF1 gene) within the adrenal glands does not change
from when it is first detected at E9 until the organ is developed. When the cortex and
medulla begin to differentiate Sf-1 expression is limited to the cortex of the adrenals.
From E18 until6 days postpartum (6dpp), steroidogenic factor-1 expression is barely
detected. Within undifferentiated gonads Sf-1 can be detected in high levels until
E12.5, around the same time gonads differentiate into male or female genitalia. At this
point, expression levels rapidly decrease within the ovary and begin to increase again
at E18. Within the testis, expression levels remain high throughout gestation, located
within the Sertoli cells and Leydig cells. Human data regarding Steroidogenic factor-1
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expression has not yet been obtained yet it is known that SF-1 expression is detected
at 32 days post ovulation (32dpo), which is the same time as the adrenogenital
primordium appears within the urogenital ridge, therefore displaying similar
expression patterns to those found within the mouse (Valet al, 2003).

Studies using adult mice have shown that Sf-1 is also detected within the ventromedial
hypothalamus (VMH) and the pituitmy gland. Homozygous knockout mice possess a
structuJ;"ally abnormal VMH and do not express
FSH~

LH~

(Lutenising Hormone beta) or

(Follicle Stimulating Hormone beta) within gonadotrope cells. These beta

subunits of the FSH and LH genes are responsible for the interaction of the hormone
with the specific hormone receptor. Regardless of genotype, these mice also exhibit
female external genitalia, lack of adrenal glands and the presence of Mullerian ducts.
Death occurs by day 8 after birth due to acute mineralocorticoid and glucocorticoid
deficiency as a consequence of the absent adrenals. Prior to sexual differentiation,
these abnormalities are not present. At E12-12.5, when sexual differentiation
normally occurs, the gonads degenerate by apoptosis. This data conveys the necessity
of SF-1 for the differentiation and maturation of cells within the gonads and adrenals,
and that its expression is not needed for the actual formation of these organs (Val et
al, 2003).

Within humans there are three different SF-1 mutations that have been reported; the
heterozygous G35E mutation, the heterozygous R255L mutation and the homozygous
R92Q mutation. The G35E mutation causes complete sex reversal of a genotypically
male individual and is also characterised by acute adrenal insufficiency. The R255L
mutation causes adrenal insufficiency yet doesn't have any effect on the ovaries of
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genotypically female individuals. The R92Q mutation causes agenesis of the right
adrenal gland, adrenal hypoplasia of the left adrenal and complete sex reversal. It is
clear through these abnormalities that SF-1 is necessary for the differentiation of the
testis as well as the degeneration of the Mullerian ducts (Valet al, 2003).

2.1.3 WTl

The Wilm's tumor-associated gene or WTJ encodes a number of proteins that are
involve;! in kidney and gonad development. It is necessary for the establishment of
the bipotential gonad and for the development of the testis once they have
differentiated. This gene which is composed of 10 exons is complex, with the
capability of forming 24 different isoforms through the use of different start sites,
RNA editing and splicing. Through alternative splicing within exon 9, isoforms are
formed either with or without the specific amino acids KTS (Lysine-ThreonineSerine). This triplet causes the loss of DNA binding capabilities by the fourth zinc
finger. The specific isoforms that are produced are either +KTS which may possibly
play a role in RNA processing or -KTS which are themselves transcription factors
that activate or deactivate transcription (Morrish and Sinclair, 2002).

Wtl expression can be detected as early as E9.5 within the mesoderm, adrenal glands,

gonads and kidneys of developing mice. By El0.5 expression is detected within the
coelomic epithelium of both sexes and later in development becoming localised in the
Sertoli cells of the male and epithelial cells of the female gonad. Homozygous
knockout mice do not survive past mid-gestation and characteristically are lacking
gonads, adrenal glands, kidneys and have defects within their heart and spleen.
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Heterozygous knockout mice who have either the +KTS or -KTS isoforms survive to
birth but die shortly after due to kidney abnormalities (Morrish and Sinclair, 2002).

Depending on which isoform is present, these knockout mice have phenotypically
different gonads, which conveys a different function for each of the isoforms within
sex determination. Mice with only the +KTS isoform present do not develop past the
streak stage and degenerate by means of apoptosis. Those expressing the -KTS
isofollll do develop gonads but all male individuals are completely sex reversed. The
expression of Sry within those mice with only the -KTS isoforms is markedly
decreased, therefore suggesting a role in SRY expression. These results propose that
the -KTS isoform must be essential for the formation of the bipotential gonad and
+KTS has a role in male sex differentiation, possibly by allowing enough Sry
expression to ensure a male sexual pathway develops (Morrish and Sinclair, 2002).

2.1.4DMRT1

This doublesex and mab-3 related transcription factor 1 (DMRTJ) gene contains a
DNA binding motif called the DM domain. This domain and its specific expression
within the testis led researchers to believe this gene was involved in the sex
determination pathway. The DMRTJ gene is the only gene that is conserved among
Caenorhabditis elegans, Drosophila and mammals. The location of the human DMRTJ
gene has been mapped to the short ann of chromosome 9 which is only 30kb from the
mutation site which causes male to female sex reversal (Lei and Heckert, 2004).

The expression pattem of Dmrtl within the mouse has provided a clue as to the
function of this gene. Before gonads have differentiated the levels of Dmrtl are very
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high. Expression levels taper off in females once their ovaries have differentiated
whereas Dmrtl remains high within Se1ioli cells of the testis from 11.5dpp (days post
pmium) right through to adulthood (Morrish and Sinclair, 2002).

Dmrtl knockout m1ce did not produce sex determination or differentiation
abnormalities until after birth. Once born, the Sertoli cells of these mice do not
complete differentiation and eventually die, producing structurally abnormal testes
with mjnimal seminiferous tubules. These tests show that Dmrtl is necessary for
Sertoli cell and germ cell differentiation within postnatal testes (Lei and Heckert,
2004).

2.1.5 GATA4

Studies by Lei and Heckert (2004) report that GATA4 is an essential transcription
factor that regulates the expression of DMRTJ. Its protein is expressed within Sertoli
cells and granulosa cells throughout gonadogenesis, being downregulated in the ovary
once they have differentiated and remaining high within the testis. A close relative of
the GATA family is Fog2, which must be present for Gata4 to function. This gene is
mainly located within the brain, heart and testis and directly interacts with Gata4 to
upregulate or downregulate its transcription (Lei and Heckert, 2004).

When the Fog2 gene is deleted in transgenic mice, death occurs in mid-gestation due
to severe abnormalities of the cardiac system. Another characteristic of these mice is
that their testes fail to differentiate, which is the same abnormality seen in
homozygous Gata4 knockout mice. These results suggest that the abnormalities in
male gonads develop due to the loss of interaction between Fog2 and Gata4 rather
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than the mutation on their own. The expression of Sf-1, Wt1 and Gata4 was not
detected in the mutant mice beyond 12.5dpc in male mice. Gata4 binds to three
control elements within the promoter of Dmrt1. Without the presence of Fog2, Dmrt1
expression is markedly decreased. Therefore Fog2 must activate Gata4 which in tum
activates the expression of Dmrt1 (Lei and Heckert, 2004).

2.1.6DAX-1

Dosage ~"sensitive sex-reversal adrenal hypoplasia congenita-critical region of the X
chromosome, gene 1 (DAX1) is a gene located on the X chromosome and when
duplicated can cause male to female sex reversal. Like SF-1, DAX1 is an orphan
nuclear hormone receptor due to its unknown ligand. Once sex determination has
occurred, Dax1 is expressed in Sertoli and Leydig cells of the testis and the somatic
cells within the ovary. In late development and throughout adulthood, expression is
localised to the Leydig cells within the testis and thecal and granulosa cells in the
ovaries (Morrish and Sinclair, 2002).

As both Sry and Dax1 are expressed within the same tissues at the same time, it is
thought that Dax1 antagonises the function of S1y. Further evidence for this comes
from transgenic mice studies in which the expression of Dax1 and S1y results in a
phenotypically and genotypically female mouse. Yet if the Dax1 gene is deleted
leaving just the S1y gene, the mouse develops as a male which confirms Dax1 inhibits
Sry function so the genotypically female mouse can follow the female developmental
pathway (Morrish and Sinclair, 2002).
Numerous in vitro studies have provided evidence for Dax1 having an inhibitory
effect on Sf-1 transcription yet the exact mechanism behind this inhibition is unclear.
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Proposed mechanisms are protein-protein interaction, DNA binding or through the
use of co-repressors. It is possible that a combination of all three mechanisms may be
used to inhibit Sf-1 transcription (Crawford et al, 1998; Nachtigal et al, 1998;
Zazopoulos et al, 1997).
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CHAPTER THREE

Sex Differentiation of the Reproductive System

3.1 The Bilaminar Germ Disc
Once an ovum has been fertilised the single cell undergoes the process of cleavage,
which is a series of divisions that increase the cell number but not the cell size.
Between days 7 and 10 of gestation the ovum has become a 32-64 cell blastocyst,
consisting of an outer cellular layer named the trophoblast, an inner layer of cells
called the inner cell mass (ICM), and a fluid filled cavity termed the blastocyst cavity
as seen in Figure 1. The trophoblast differentiates into the embryonic placenta, whilst
the ICM divides into two more cellular layers, the hypoblast and epiblast. Once these
two layers have formed at the end of the second week, the developing embryo bas
become the bilaminar germ disc. The trophoblast also undergoes morphogenetic
changes as it divides into an outer syncytiotrophoblast layer and an inner
cytotrophoblast layer (Larsen, 2001 ). The syncytiotrophoblast layer fom1s lacunae, in
which the maternal blood vessels can provide nourishment. The cytotrophoblast
differentiates into extraembryonic mesoderm that serves to provide nourishment,
protection and a means for respiration for the developing embryo (Kalthoff, 2001 ).
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Figure 1 - The Bilaminar Germ Disc (Marieb, E., 2006, pp 1115).
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3.2 The Trilaminar Germ Disc
3.2.1 The Primitive Streak

At approximately day 15 of development a longitudinal groove along the midline of
the epiblast begins to form on the bilaminar germ disc, becoming the primitive streak.
By day 16, an elevated area of epiblast cells forms a mound at the cranial region of
the bilaminar germ disc hence forming the primitive node. The primitive streak is an
important structure in embryonic development as it outlines the longitudinal axis of
the emb,ryo (Larsen, 2001).

3.2.2 Layers of the Trilaminar Germ Disc

The epiblast cells on either side of the primitive streak begin to proliferate and flatten
in preparation for migration at approximately day 16. Once these cells are structurally
capable, they migrate through the primitive streak to rest between the epiblast and
hypoblast. The invasion of numerous epiblast cells into the hypoblast forms what will
be called the endodermallayer. Other epiblast cells migrate between the epiblast and
endoderm forming another layer of the trilaminar gem1 disc, the mesoderm. Once the
endoderm and mesoderm are formed the epiblast is now termed the ectoderm layer
and the structure has become the trilaminar germ disc as seen in Figure 2. These three
layers differentiate to become specific organs and tissues within the embryo (Larsen,
2001). The ectodermal layer gives rise to the dermis, brain, spine, neurones and sense
receptors. The mesodermal layer forms the notochord, muscles, blood, bone and the
sex organs, while the remaining endodermal layer forms the lining of the gut, lungs
and bladder and forms the liver and pancreas (Kalthoff, 2001).
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Figure 2- The Trilaminar Germ Disc (Martini, 2005, ppl 071).

3.3 Germ Cells and Gonad Formation
During the second week of development, cells from the epiblast layer produce the
female and male gametes. These cells will eventually detach from the ectodennal
layer and become primordial germ cells within the yolk sac. At the 4-6 week stage the
primordial germ cells migrate again into the wall of the gut tube and attach to the
midline of the body wall at the 1Oth thoracic vertebral level. These cells will then
differentiate into the future gonads (Larsen, 2001 ).

3.4 Hormonal Regulation of Sex Differentiation
Hom1one activity within the ovaries is not a crucial element in sex differentiation for
females , whereas males require testosterone and Mullerian Inhibiting Hormone (MIH)
in order to produce the male Wolffian ducts. The Wolffian system constitutes the vas
deferens, epididymis and seminal vesicle of the male reproductive tract. The
Mullerian system is the reproductive tract of females and includes the oviducts,
uterus, cervix and part of the upper vagina. Between the 8

111

and 10

111

weeks of

development the Se11oli cells within the testes of the male embryo begin to secrete
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MIH. This hormone is of extreme importance as it causes the degeneration of the
Mullerian ducts so development can follow the male pathway. If this hormone is not
released, the Mullerian ducts will remain within the embryo producing a child with
both male and female genitalia. The Mullerian ducts do not require the presence of
ovaries in order to differentiate and develop. When a female embryo has its ovaries
removed, the internal genitalia still develop as a female despite the absence of ovarian
activity (Larsen, 2001).

Homozygous deletions within the coding region of the MIH gene produces normal
testes in transgenic mice, yet they are sterile due to the presence of Mullerian ducts
that interfere with the transfer of sperm. Therefore it is clear that MIH is not necessa1y
for testis determination as testes still develop when MIH is deleted from the genome.
Rather it is essential for ensuring a genetically male individual has only the male
Wolffian ducts (Morrish and Sinclair, 2002).

MIH expression appears to be tightly regulated, with varymg expressiOn levels
throughout development and adulthood. Within male rats, MIH is expressed in Se1ioli
cells as soon as testes have differentiated at approximately 13dpc. After bi1ih levels
remain high until day 5 where it drastically decreases to a low level at which it
remains throughout adulthood. Expression of MIH in female rats can be detected at
low levels within foetal ovaries and is expressed at higher levels after birth within
developing follicles. Many factors have been suggested to be involved in the
regulation of MIH expression such as SOX9, SRY, WT-1, GATA4 and DAX-1. All
except DAX-1 and WT-1 are able to bind to a region -180bp upstream from the MIH
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start site and expressiOn of all of these factors occurs before MIH 1s expressed
(Watanabe et al, 2000).

Many studies have concluded that SOX9 is the number one candidate for the
upregulation of Mullerian inhibiting hormone. In vitro, SOX9 binds to the MIH
promoter that has a HMG box binding site. Mice carrying homozygous mutations in
the Sox9 binding site in the MIH gene produce a phenotype the same as those
carrying deletions in the MIH coding region. Other evidence derives from human
mutations in the SOX9 gene itself. These XY individuals have Mullerian-like
stmctures due to the proposed lack of MIH protein. It is believed that the absence of
SOX9 means MIH is not upregulated and the Mullerian stmctures remain (Morrish
and Sinclair, 2002). The over-expression of MIH in female transgenic mice produces
what is called the freemartin effect. If a female mouse is exposed to the blood of a
male twin whilst developing, the female mouse somewhat develops as a male due to
the MIH exposure. Ovarian germ cells degenerate and Sertoli cells form within
seminiferous tubules (Lane and Donahoe, 1998).
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CHAPTER FOUR

Sex Differentiation Abnormalities
4.1 Hermaphrodites
It is evident that the presence of the SRY gene is the first step in sex differentiation
towards a male phenotype, its absence producing a female phenotype. In rare cases
this mechanism can fail and individuals can be born with male and female internal
and/or external genitalia due to a mutation associated with the SRY gene. Such cases
are termed true hermaphrodites and are genotypically a mosaic of XY, XX or XO
cells. Due to the ambiguous external genitalia, sex is hard to determine at bilih which
has led to many individuals being raised as the wrong sex (Queipo et al, 2002).
Secondary hermaphrodites can arise when there is a communication failure between
the requisite hormones, such as testosterone and MIH and the internal or external
genitalia. This abnormality also produces an individual with a mix of female and male
tissue types. As this form of hermaphroditism is due to a hormone abnormality,
females tend to become more virilised and males more feminised (Johnson and
Everitt, 2000).

True hermaphroditism (TH) is the maJor fonn of sex reversal that produces an
individual with both ovarian and testicular tissue regardless of genotype. This occurs
in the form of either an ovotestis (single gonad) or a testis on one side and an ovary on
the other. Depending on the amount of testicular tissue that is present and therefore
the amount of MIH that is secreted, affected individuals will have varying
development of both Wolffian and Mullerian structures (Queipo et al, 2002). Many
studies on true hermaphrodites have shown that 60% of individuals have a 46XX
karyotype, 33% are mosaics with a Y chromosome in a second cell line and the
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remaining 7% have a 46XY genotype (Hadjiathasiou et al, 1994; Krob et al, 1994;
Salas-Cortez et al, 2000).

Only a small number of 46XX true hermaphrodite's have Y-DNA sequences therefore
the mechanism leading to testicular tissue in these individuals is unknown. It has been
hypothesised that mutations in X-linked or autosomal genes may cause a gain of
function in the gene which could explain the development of male characteristics with
the absence of SRY. In a study by Queipo and colleagues (2002), only 14% of
testicular cells were found to have the SRY protein. It is thought that this low
percentage of SRY is not enough to produce male genitalia and therefore leads to the
production of ovotestes (Queipo et al, 2002).

4.1.1 Testicular Feminisation

Testicular feminisation (Tfm) also known as Androgen Insensitivity Syndrome, is an
example of abnormal sex differentiation that can produce secondary hermaphrodites.
These individuals have a 46XY karyotype yet are phenotypically female due to a lack
of virilisation during development. This abnormality is a result of mutations occurring
in the androgen receptor gene located on the X chromosome which causes the
receptors themselves to be insensitive to the effects of testosterone. Endocrine
research has shown that testosterone levels are twice as high in the testicular vein as
opposed to the peripheral blood, signifying that testosterone biosynthesis is normal
(Regadera et al, 1999).

Testicular feminisation can occur in two forms, complete and incomplete. The
complete form produces an individual with an XY genotype and is completely

19

feminised. The incomplete form produces varymg degrees of external genital
ambiguity and feminisation, depending on the level of compromise of androgen
receptor function (Holterhus et al, 2003) . A number of studies have focused on the
testes of children affected with Tfm (Regadera et al, 1999, Salas-Cortes et al, 2000).
Their findings show that the number of spem1atogonia are normal until the individual
reaches puberty. At this stage the numbers dramatically decrease and the
spermatogonia become hype1irophied (Regadera et al, 1999).
,-

4.2 Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia (CAH) categorises a group of recessive disorders that
affect the biosynthesis of cmiisol by the adrenal gland (Figure 3). The severity and
symptoms of the disorder depend on the enzyme that is affected within the cortisol
biosynthesis pathway. The impairment in cortisol synthesis causes chronic stimulation
of Adrenoco1iicotrophin honnone (ACTH) as there is no negative feedback to stop its
production. This in turn causes an excess of steroid hormone precursors and affects
the production of glucocorticoids and mineralcorticoids from the adrenal cmiex (New,
1998).

Figure 3 -Early human adrenal fimcti.on and androgen Nosynthesis implications
(Goto, M eta!, 2006, p958).
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CAH can occur in classical and non-classical forms which produce varymg
symptoms. Classical forms are apparent in childhood with an extreme overproduction
of cortisol precursors and sex steroids. If an individual has a severe case of the
classical form, they suffer from excessive salt loss due to an inhibition of aldosterone
preventing reabsorption of sodium within the kidneys. Female children are born with
ambiguous external genitalia due to the excess exposure of androgens in utero as seen
in Figure 4. The clitoris is enlarged resembling a penis and the labia majora tend to be
fused together. Internally these individuals have normal ovaries, uterus and fallopian
tubes without any Wolffian structures. Male infants do not present with obvious
symptoms at bilih and are only diagnosed when the individual begins to lose salt
excessively between 7-14 days after bilih. Salt wasting presents with vomiting,
dehydration, hyponatraemia (low blood sodium concentration), hypokalaemia (low
blood potassium concentration) and shock. Most female infants do not reach this stage
of the illness as the ambiguous external genitalia leads to early diagnosis. (Merke and
Bornstein, 2005).

Figure 4- Ambiguous genitalia offemale infant due to excessive androgen exposure
(Nelson, C. and Gearhart, J., 2004).
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The non-classical form of CAH presents without a cortisol deficiency yet individuals
have hyperandrogenism in childhood or early adulthood. Pubarche begins early with
60% of affected females presenting with excessive hair growth (hirsutism), 54% with
amenorrhoea and 33% with polycystic ovaries and acne (New, M., 1998).

4.2.1 21 Hydroxylase Deficiency

The most common cause of CAH arises from a 21-Hydroxylase deficiency. The 21hydroxylase gene is located on chromosome 6p21.3 and has an active gene

'
(CYP21A2) and a non-active gene (CYP21AIP) that are highly homologous. Most
mutations that cause this form of CAH arise from recombination between the active
and non-active gene which generates non-transcribing alleles on the active gene
(Merke and Bomstein, 2005).

4.2.2

17 j3-Hydroxysteroid Dehydrogenase 3 Deficiency

Another Congenital Adrenal Hyperplasia disorder that results in the development of
secondary hermaphrodites is
(17[~eta]-HSD3).

17-~eta

Hydroxysteroid Dehydrogenase 3 Deficiency

This abnormality arises from a mutation that affects the conversion

of androstenedione to testosterone within the testes of the male embryo. Affected
males more often than not are born with testes, the vas deferens, epididymis,
ejaculatory ducts and female external genitalia. At birth the sex of the child is usually
determined to be female, yet at puberty changes occur that can alter the individual's
perceptions of their own gender. Androstenedione levels within the blood
dramatically increase causing an increase in serum testosterone. Many affected
individuals change their gender role from female to male after puberty due to the
masculinization caused by testosterone (Mendonca et al, 2000).
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4.3 Role of Sex Differentiation Abnormalities
Defects in androgen production or function can lead to genital ambiguity at birth.
Over-expression or under-expression of important sex hormones can have extreme
side effects. The study of such disorders thus provides scientists with evidence of the
strength of androgens and their effects on the body (Witchel, 2002).

4.4 Sex Differentiation Abnormalities in Lab Animals
Rat stlJdies have proven to be an asset in the study of brain structure, hormones and
gender behaviours. The rodent's brain does not completely develop until after bi1ih
therefore enabling scientists to manipulate certain brain structures or hormones before
the brain has fully developed and observe their effects (Moir and Jessel, 1991).

4.4.1 Hormone Manipulation in Rodents

Castration of a male rat soon after birth causes the rodent to act in a characteristically
female maimer. The later the rat is castrated the less obvious the female behaviour as
the brain has had time to develop along the male pathway and so adapt to the
influence of testosterone. Administration of testosterone to the rodent at certain stages
of development following castration has varying effects on its behaviour. If the
testosterone is administered too early there is little effect on the developing brain,
since it has not yet reached the stage in which it is sensitive to androgens. Once the
brain of the rodent has completely developed, hormone manipulation has no effect on
the brain or behaviour as it has already been fixed into a male or female pattern (Moir
and Jessel, 1991).
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4.4.2 Non-Human Primates

Many studies have been conducted on rhesus monkeys in relation to androgens and
behavioural aspects. Female monkeys that have been exposed to high levels of
testosterone prenatally exhibit behavioural patterns of male rhesus monkeys. These
androgenised females are capable of performing a mature mounting pattern that only
male rhesus monkeys otherwise can achieve. Studies show that, despite this mounting
pattern and male-like rough behaviour whilst interacting with other monkeys,
androgenised females do not have a completely male patterned brain. They exhibit
successful interaction with males and are able to become pregnant. Compared to
rodents, it is clear that non-human primates do not undergo complete androgenisation,
suggesting there is a critical androgen-sensitive period during foetal life that has yet to
be determined (Graves, 2006; Johnson and Everitt, 2000; Keefe, 2002; Rehman et al,
2004).
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CHAPTER FIVE

Variations in the Sexual Differentiation of the Central Nervous System

Sex differentiation within the brain has been a topic of controversy for decades.
Numerous experiments on animals have proved sexual dimorphism within certain
structures of the brain, yet similar studies on human brains have produced mixed
results. Different laboratory techniques, sample sizes and study methods are all
attributed to the varying results that are published in regards to brain sexual
dimorphism. Despite the negative aspects of this research topic the positive results
cannot be ignored (Sommer et al, 2004).

5.1 Cerebral Cortex
The greater size and weight of the male cerebral cortex in comparison to the female
cortex is a sexually dimorphic trait that has been well established for over three
decades (Kretschmann et al, 1979). Rabinowicz and colleagues (2002) reported a
neuronal density that is 15% higher in males than females with a greater difference
occurring in the right hemisphere. This higher neuronal density could be a factor
contributing to the larger size and weight of the male cortex. The greater number of
neuronal cells present in the male cortex would suggest a corresponding greater
number of axons. This is thought to be the reasoning behind the finding that males
have an increased volume of white matter as opposed to females (de Courten-Myers,
1999).

The different cognitive abilities of males and females are attributed to the varying
volumes of grey and white matter within the cerebrum. Females excel in verbal
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memory tasks, speed of articulation and verbal fluency tasks whilst males perform
better at visuospatial tasks (Sommer et al, 2004). The higher volume of grey matter
within the female cortex is thought to contribute to the bilateralism of the female brain
and the ability to use both hemispheres for language functions (Gur et al, 1999).

Stroke victims have provided evidence for the bilateralism of the female brain. After
lesions to the left hemisphere, the area associated with verbal tasks, females show less
impairment in their verbal abilities than males. Functional activation studies have
shown that the right hemisphere compensates for the impairment of the left
hemisphere enabling females to regain their speech abilities earlier than males and to
be less severely affected (Sommer et al, 2004).

A morphometric study conducted by Rabinowicz and colleagues (1998) demonstrated
that the female cerebral cortex consists of more neuropil than males. The neuropil is a
conglomeration of glial processes, synaptic neurons, axons and dendrites within nerve
cells of gray matter. This increase in neuropil volume within females suggests more
connections between cells and a more extensive dendritic network which could
account for the bilateralisation of both hemispheres (de Courten-Myers, 1999).

The right ventromedial prefrontal cortex (VMPC) is another structure of the cerebrum
that appears to be sexually dimorphic. This area is associated with emotional
processing, social functioning, personality and decision making. In a recent study
using functional imaging, decision making predominantly activated the right VMPC
in males whilst the left side was activated in females. As expected, male individuals
with lesions in the right VMPC produced severe impairments in the normal
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functioning of this area, whilst lesions in the left produced minor results. Lesions in
the left VMPC in females produced the same defects in social functioning whereas
lesions in the right produced only minor disturbances (Tranel et al, 2005).

5.1.1 Corpus Callosum

The corpus callosum (Figure 5) is a network of over 200 million nerve fibres that
allows the two cerebral hemispheres of the brain to communicate with each other
(Narr et,- al, 2000). This structure is divided into three main parts, the anterior portion
or rostrum, the central portion known as the isthmus and the posterior portion, the
splenium. There has been much debate as to whether there are definitive sexual
differences in the size or shape of the corpus callosum. It is understood that the
overall size of the corpus callosum is larger in females than males and that the
splenium region is of a more bulbous shape (Rabinowicz et al, 2002).

Figure 5- Midsaggital section of the brain showing the corpus callosum and other
surrounding structures (Marieb, 2006, pp458).

27

The function of the larger corpus callosum in females is thought to be related to the
bilateralisation of the two cerebral hemispheres. This increased volume of fibres may
permit the activation of both hemispheres via the crossing over of information through
this dense network (Rabinowicz et al, 2002).

5.2 Hypothalamus
The hypothalamus contains numerous nuclei that have been repmied to be sexually
dimorphic (Figure 6). These sex differences are thought to be related to reproductive
behaviour, gender identity and sexual orientation, as well as differences in prevalence
of certain disease states (Swaab et al, 2003).
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Figure 6- Main Hypothalamic Nuclei (Marieb, 2006, pp 446).

5.2.1 Preoptic Area of the Hypothalamus

The preoptic area is a pmiion of the anterior hypothalamus that is divided into four
nuclei, the lateral, medial and median preoptic nuclei and the pariventricular nucleus,
all of which are larger in the male. The median preoptic nucleus, as well as the lateral
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and medial divisions, are 50-70% larger in total volume in males. The lateral preoptic
nucleus also contains 28% more neurons in males and the medial preoptic nucleus
contains 21% more neurons. Rat studies have shown that the increase in size is due to
an increase in neuronal numbers. The median preoptic nucleus of the male contains
80% more neurons than females due to the sexually dimorphic nucleus found within
this region (Madeira et al, 1999).

,-5.2.2 Sexually Dimorphic Nucleus (SDN)

This division of the medial preoptic area has been an important finding in this field as
most studies convey the same results. Sexual dimorphism of the rat SDN was first
described by Gorski and colleagues (1978) as being three to eight times larger in male
rats than female rats (Figure 7). The human sexually dimorphic nucleus homologous
with the rat SDN has been discovered and revealed to be twice as large in young adult
males with twice as many cells when compared to females. The SDN is associated
with the sexual behaviour of both males and females, and with sexual identity (Swaab
et al, 2003).

(A)

(B)

(C)

(D)

Figure 7- Sexually Dimorphic Nucleus of the preoptic area in (A) male rat, (B)
female rat, (C) female rat perinatally treated with testosterone and (D) female
rat treated with oestrogen (Kalthoff, 2001, p726).
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Swaab and Hofman (1995) found that lesions within the SDN caused the male rats to
become less masculine. However they believed the change in behaviour was so
minute that gender identity is not a main function of the SDN, otherwise the changes
observed would have been more significant. De Vries' (2004) study supports that of
Swaab and Hofman (1995), reporting that lesioning of the SDN does not produce
significant changes in the male rats' behaviour.

In humans the age at which the SDN sexually differentiates and takes on a male or
female pattern is between two and four years. Before this period there are no apparent
sexual dimorphisms and the cell numbers are only 20% of the adult size. Once a
female has reached four years of age, the cell numbers rapidly decrease whereas the
male SDN remains at a constant until approximately 50 years of age, when the cells
begin to die via apoptosis. Females experience their second phase of cell loss at
approximately 70 years of age where cell numbers reduce to 10-15% of childhood
values (Swaab et al, 2003).

In an attempt to ascertain the effects of testosterone on the size and cell number of the
SDN, Von Esenwein and Silke (2005), manipulated female rat brains by introducing
testosterone propionate. The results of this proved that testosterone is important in
sexual differentiation of the brain, in particular the SDN, as the female rats exhibited a
decrease in lordosis (copulatory posture), increased mounting and an increase in cell
numbers similar to that of the male rat.
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5.2.3 Suprachiasmic Nucleus (SCN)

The function of this nucleus is to co-ordinate circadian and seasonal rhythms in
locomotor activity, sleep, endocrine function and sexual behaviour. It is sexually
dimorphic in rodents and humans, but not in the same way. The male rat SCN is
larger than the females yet it is the shape of the nucleus that differs between the
genders in humans. In females the SCN is more elongated whilst in males it is of a
more spherical shape (Abizaid et al, 2004; Hofman et al, 1996; Swaab, 1995).

Studies of some homosexuals have provided evidence for the function of the sexual
dimorphism in the SCN. Morphometric analysis showed that the volume of the SCN
in a group of homosexual males was 1. 7 times larger with 2.1 times as many cells
than the group of heterosexual men. Programmed cell death of the SCN cells occurs
between 13 and 16 months after birth. As homosexuals have the same number of cells
as 1-2 year old children it is thought homosexuals do not undergo the same apoptotic
mechanisms within the SCN as heterosexuals (Swaab et al, 2003). Proliferation of rat
SCN cells occurs between E 13 and E 17, peaking at E 15. This proliferation occurs
when aromatase activity (conversion of testosterone to estradiol) is at a high within
the hypothalamus, suggesting that estradiol can alter the number of cells that
proliferate within the SCN. Estradiol has been confirmed as being a neuroprotective
agent by decreasing programmed cell death which could account for the increased cell
numbers located within the male rat SCN (Abizaid et al, 2004).

5.2.4 Bed Nucleus of the Stria Terminalis (BNST)

The stria terminalis is a long mass of grey matter fibres that conveys information from
the amygdala to the hypothalamus (Chung et al, 2000). Two regions within the BNST
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have been found to be sexually dimorphic, the darkly staining postereomedial
component of the BNST (BNST-dspm) as well as the central division (Allen and
Gorski, 1990, Chung et al, 2002, Garcia-Falgueras, 2005). The central division of the
BNST (BNSTc) has been linked with transexuality as studies show that the size of
BNSTc in male to female transsexuals is similar to that of the control group of
females as seen in Figure 8 (K.IUijver et al, 2000).
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Figure 8- Immunocytochemical staining of somatostatin neurons in BNSTc of (a)
heterosexual male, (b) heterosexual female, (c) homosexual male, (d) maleto-female transsexual. The transsexual has a BNSTc similar in size to the
female (Kruijver eta!, 2000 p 2037).
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Sexual dimorphism in the rat BNST occurs within the first week of birth as a result of
differences in testosterone levels. Within humans, sex differences don't reach
significance until adulthood when it is clear the BNST is larger in males than females.
In female rats once the BNST has fully differentiated, no amount of circulating
testosterone can increase its volume. The bed nucleus of the stria terminalis
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gonadectomised male rats does not decrease in volume due to a decrease
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testosterone levels, suggesting that once this structure is differentiated, testosterone is
not neyded to maintain its volume (Chung et al, 2002).

It is believed that sex differences in the size and cell number of the bed nucleus of the

stria terminalis within humans occurs due to increased programmed cell death
(apoptosis) in females. A study by Chung et al (2000) has reported there is an increase
in apoptosis within females which accounts for the smaller BNST size and cell
number. Gonadal steroids appears to be the cause of this difference in apoptosis as
castrated males and female rats treated with testosterone experience a decrease in
apoptotic cell death (Chung et al, 2000).

5.4 The Anterior Commissure

This structure is a small bundle of nerve fibres between the two cerebral hemispheres
much like the corpus callosum. As females appear to use both hemispheres more often
than males it is thought that the anterior commissure would therefore be larger in
females than males. Many studies have concluded that the anterior commissure is on
average 12% larger in females than in males (Allen and Gorski, 1992; Moir and
Jesse!, 1991; Swaab and Hofman, 1995), whilst others have reported no sex
differences in rats or humans (Bishop and Wahlsten, 1999; Highley et al, 1999; Jones

33

et al, 1997). The anterior commissure is not present in all individuals but is present in
approximately 78% of females and 68% of males, again more evidence for the
bilateralisation of the female brain (Swaab et al, 2003). More studies need to be
conducted on the anterior commissure, with larger sample sizes and more thorough
statistical analysis in order for a conclusion to be made on the sexual dimorphism of
this structure (Lasco et al, 2002).

5.5 Amygdala
The amygdala is an almond shaped structure comprised of numerous nuclei located
within three regions, the basolateral nuclei, corticomedial nucleus and the central
nucleus (Bear et al, 2001). Once total brain size has been taken into account the
human amygdala is much larger in males than females (Cahill et al, 2004; Durston et
al, 2001; Goldstein et al, 2001 ). Within rats, the posterodorsal component of the
medial amygdala has been found to be 50-80% larger in males (Cooke et al, 1999),
with an increased volume of neurons in the posteromedial region (Rasia-Filho et al,
2000).

The amygdala's role within the brain is to receive afferent signals from the olfactory
bulb and project them to the hypothalamus, stria terminalis, preoptic area and the
remainder of the limbic system (Cooke et al, 1999). It is also implicated in sexual
arousal, reproductive behaviour, emotional memory and fear (Hamann, 2005).
Females and males process emotionally arousing events differently as revealed by
positron emission tomography (PET) and functional magnetic resonance imaging
(fMRI). Long te1m memory for arousing material was found to be located within the
right hemisphere of the amygdala in males and the left hemisphere in females (Cahill
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et al, 1996, 2001, 2004; Canli et al, 2002). In a study by Cahill and colleagues (2001),
males and females watched either highly aversive or neutral films whilst their brain
activity was measured with PET. When asked about these films at a later date (long
term memory), the same results were produced, the left hemisphere in females was
activated whilst the right hemisphere was activated in males.

Psychological studies have shown that there are sex differences in emotionally related
behav~our.

Females are said to retain more vivid memories for an emotional event and

are able to recall them at a quicker rate. The greater prevalence of anxiety and
depression in females has been postulated to be due to this enhanced ability to
remember details of certain events (Hamann, 2005). Bilateral lesions in the amygdala
reduce long term memory of emotional events but do not affect memory for neutral
events. This provides evidence that the amygdala's role in memory is for events that
are emotionally arousing as opposed to neutral events (Cahill et al, 2004).

Kluver and Bucy (1939) recognised that rhesus monkeys with damaged temporal
lobes had a distinct behavioural pattern. Normal fear and anger responses were lost,
they were unable to visually recognise objects and exhibited an increase in sexual
behaviour. This was later called the Kluver-Bucy syndrome and has been recognised
in humans with temporal lobe damage. Humans also experience a somewhat dulling
of all the emotions, not just fear and anger as in rhesus monkeys. As the entire
temporal lobe was removed, structures other than the amygdala could account for
some of these odd behavioural characteristics. The inability of the rhesus monkeys to
recognise objects, would be due to the loss of the visual areas within the temporal
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lobes, yet the emotional and sexual behavioural characteristics are believed to be
attributed to the loss of amygdaloid function. (Bear et al, 2001 ).

Appetitive sexual behaviour, which is the motivation and enthusiasm exhibited to
receive a sexual reward, is a sexually dimorphic trait within rats. The amygdala is
essential for male appetitive sexual behaviour but does not play a role in female
appetitive sexual behaviour. Lesions to the medial amygdala in male rats decreased
their ability to respond to sexual cues from the female whereas these lesions within
the female did not affect her sexual behaviour (Hamam1, 2005).

36

CHAPTER SIX

Sexually Dimorphic Distribution of Disease

Throughout the long history of human disease, ce11ain diseases and disorders have
more commonly affected one sex than the other. The question is whether this pattem
of disease distribution is due to sexual dimorphism or to another as yet undiscovered
mechanism. A number of correlations have been found between certain diseases and
the levels of circulating androgens yet few workers have reported a relationship
between brain structure and the incidence of disease.

6.1 Schizophrenia

Schizophrenia is a psychiatric disorder in which individuals experience episodes of
hallucinations, delusions, psychosis and paranoia leading to social withdrawal,
impaired attention and cognitive dysfunction (Cyr et al, 2002). A study by
Angermeyer and Kuhn (1988) examined 36 research papers on schizophrenia and the
age of onset between genders. All except three showed that males develop
schizophrenia at an earlier age than females. More recent studies have published
similar results and conclude that not only are the incidence rates for the disease lower
in females but they also respond better to treatment, exhibit better social functioning
and develop less severe symptoms than males (Bryant et al, 1999; Cyr et al, 2002;
Nopoulos et al, 1997; Takahashi et al, 2000).

It has been proposed that the reason females are not affected as severely and as early

as males is due to the protective role of oestrogen (Cyr et al, 2002; Fink et al, 1998;
Hafner et al 1991; Hafner, 2003; Sumner et al, 1999). It is known that relapse rates
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increase when oestrogen levels are low in the female menstrual cycle, and decrease
when oestrogen levels are high (Cyr et al, 2002). Short-term applications of oestrogen
in rats produces a weak neuroleptic effect by reducing the affinity of dopamine
receptors. A reduction in dopamine receptor sensitivity has been shown to have
neuroprotective and antipsychotic effects which may be the reason female
schizophrenics have a better prognosis in terms of age of onset and disease severity
(Hafner, 2003)

Many studies have found that the .parietal lobe may be a factor in the cause and
severity of schizophrenia (Frederikse et al, 2000; Kaplan et al, 1993; Wigal et al,
1997). The parietal lobe is associated with perception, attention, recognition and
visuospatial processing, all of which are abnormal in schizophrenic patients. The
volume of the inferior parietal lobe is much larger in healthy males than in females
yet in male schizophrenics the volume is significantly smaller when compared to
female schizophrenics. Therefore abnormalities in inferior parietal volume appear to
be limited to male schizophrenics. The left side of the brain, which nonnally
dominates rn healthy male individuals, tends to lack in function in male
schizophrenics, whereas no such finding has been made in female schizophrenics. It is
believed that the bilateral brains of females' enables those affected with schizophrenia
to cope better with the disease, leading to different disease expression between
genders (Frederikse et al, 2000).

Wright and colleagues (2000) conducted a meta-analysis on 58 studies that had aimed
to determine the influence of brain morphology in schizophrenia. Of the 58 studies
from 1988 to 1998, nine of them referred to schizophrenia and gender, all of which
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did not prove significant differences in brain structure between male and female
schizophrenics. Ventricular enlargement was slightly greater in male schizophrenics
but was not of great statistical significance (Wright et al, 2000). Despite the large
number of studies that were reviewed by Wright and his colleagues (2000), the data
that was used is between 8 and 18 years old. This must be kept in mind when
reviewing this study as many advances in experimental techniques and data analysis
have been made since these studies were conducted, therefore the results obtained in
these S8 studies may not be reliable.

6.2 Autoimmune Disease
Autoimmune diseases occur as a result of immune responses being generated against
self-antigens due to a breakdown in the mechanism that allows the immune system to
recognise 'self from 'non-self. All autoimmune diseases such as systemic lupus
erythematosus, multiple sclerosis, rheumatoid arthritis, Sjogren syndrome and
scleroderma are significantly predominant in females as seen in Table 1. (Rubin,
2001).
AUTOIMMUNE DISEASE

Hashimoto Thyroiditis

FEMALE TO MALE RATIO

26:1

Graves Disease

4 to 8:1

Systemic Lupus Erythematosus

9 to 13:1

Sjogren Syndrome

9:1

Juvenile Onset of Myasthenia Gravis:
- White patients

2 to 14:1

- Black Patients

1:1

Scleroderma

3 to 4:1

Table 1 -Female to male ratio's of common autoimmune diseases (modified from
Ahmed eta!, 1999).
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6.2.1 Systemic Lupus Erythematosus (SLE)

SLE is a multisystemic inflammatory disease which predominantly affects the joints,
kidneys, skin (Figure 9) and serous membranes. Although these are the most common
sites affected in SLE, almost any organ can be affected as immune complexes can
deposit in any tissue or organ. An important feature of SLE is the development of
autoantibodies against nucleic acids which are able to cause damage via numerous
mechanisms. Antinuclear antibodies bind to free DNA, forming complexes that are
deposi}ed

m

glomeruli,

walls

of

arterioles

and

joint

synovia

causmg

glomerulonephritis, arteriole fibrosis and mihritis respectively. Autoantibodies to
platelets, red blood cells, muscles and skin are also produced causing the
multisystemic disease (Tizard, 1995).

Figure 9- Female adolescent with facia/lesions as a result of Systemic Lupus
E1ythematosus (Tizard, 1995, p498).

The immune system in females is more enhanced than that of males with a better Bcell mediated immunity, higher immunoglobulin levels, stronger antibody responses
and an increased resistance to certain infections. It is believed that sex hormones play
a vital role in systemic lupus erythematosus as the disease worsens at particular
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periods of hormone changes when oestrogen levels are high (Osman, 2003).
According to Yacoub Wasef (2004), before puberty the female to male ratio of SLE is
3: 1, during childbearing years it ranges from 10: 1 to 15: 1 and after menopause the
ratio is 8:1. Male and female SLE patients have abnormal hydroxylation of oestrogen
which produces 16 alpha-hydroxyesterone. This compound covalently bonds with
proteins such as erythrocytes and lymphocytes, resulting in antibody production
(Wasef, 2004).

Female SLE patients have lower androgen levels than healthy females and an
increased oxidation of testosterone whereas male patients have normal androgen
levels and normal oxidation of testosterone. Gonadectomised female and male mice
have been reported to have an enhanced immune response to endotoxins. Testosterone
treatment reverses this immune response suggesting a protective role of testosterone
in autoimmune diseases (Gaillard et al, 1998).

6.2.2 Rheumatoid Arthritis (RA)

This autoimmune disease differs between sex as well as age. Prevalence rates in
females increase from menarche reaching a peak at menopause, whereas it is rare for
males to have RA under the age of 45, with numbers steadily increasing in older
males before reaching numbers similar to that of females. Androgens are thought to
play a major role in this autoimmune disease as male patients exhibit low testosterone
levels. Dehydroepiandrosterone (DHEA), an adrenal gland product which is the major
androgen in females has also been found to be in low levels in RA patients. Between
20 and 30 years of age, DHEA levels reach a peak and decrease thereafter (Wilder,
1996). Despite evidence for a role of DHEA in rheumatoid arthritis, oestrogen and
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progesterone deficiency are also thought to be involved due to the menopausal peak
of the disease and the fact that oral oestrogen contraceptives can alter the disease
onset and severity (Olsen et al, 2002).

6.3 Autism
Autism is a neurodevelopmental disorder characterised by deficits in social
interaction, stereotyped repetitive behaviours, language impairments and diminished
cognitive abilities which must be apparent by three years of age (American
'

Psychiatric Association, 1994). This disorder is divided into three categories
depending on the level of cognitive dysfunction. Low-functioning autism has an IQ of
less than 70, high-functioning autism has an IQ above 70 and Asperger syndrome
which is similar to high-functioning autism, without the language deficits (Powell,
2004). It has been clearly established that autism is four times more prevalent in
males than females and Asperger syndrome is ten times more common in males, yet
the underlying mechanisms are largely unknown (Gillberg et al, 1999; Hertz-Picciotto
et al, 2006; Powell, 2004; Stone et al, 2004).

Few studies have referred to autism and the effects of gender, other than the higher
male to female prevalence rates. Thompson et al (2003) conducted a literature review
of autism to ascertain the number of studies that analysed data on female and male
autistic patients. During the period 1990 and 1992 (see Table 2), there were 392
studies found within the Psychlit database, 119 of which provided infom1ation on
prevalence rates among males and females. Of these 119 articles, 57 were conducted
using just one sex with small sample sizes, 20 analysed variables separately for each
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gender and 3 out of these 20 analysed intellectual differences between males and
females with autism (Thompson et al, 2003).

LITERATURE SEARCH FROM 1990-1992
Search for "Autism" produced= 392 Articles
Article information

Percent of 392 Articles

Information about males VS females

30%

Single sexed articles with small sample size

15%

Analysis
of variables separately for genders
,Female and male IQ considered

5%
<1%

Table 2- Number of articles with gender specific information with regard to autism
froml990-1992 (adaptedfi'om Thompson et al, 2003).

The same search was conducted for the period 2000-2002 which produced 563
articles on autism (see Table 3). Of these articles, 134 contained information on the
number of males and females within the study, and 76 of these consisted of small
sample sizes of just one sex. The separate analysis of variables for males and females
was only 12 as opposed to the 20 found in 1990-1992. Over this 10 year period there
was only an increase of 171 miicles and a 3% decrease in the number of studies that
analysed variables separately for each gender (Thompson et al, 2003). This analysis of
articles by Thompson and colleagues suggests that the information available on
autism has a bias towards males. This needs to change in order to obtain a clear
understanding of the mechanisms leading to the development and symptoms of
autism.
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LITERATURE SEARCH FROM 2000-2002
Search for "Autism" produced= 563 articles
Article Information

Percent of 563 Articles

Information about males VS females

24%

Single sexed articles with small sample size

13%

Analysis of variables separately for genders

2%

Table 3 -Number of articles with gender specific information with regard to autism
fi·mn 2000-2002 (adapted from Thompson et al, 2003).

A theory behind the behavioural aspects of the autistic brain is one that involves an
extreme masculinisation of the brain. Baron-Cohen (2002) has suggested that there
are two types of brains; the empathising brain and the systemising brain. The
empathising brain or female brain, is able to identify thoughts and behaviours of
others and is therefore able to respond accordingly. The systemising brain or male
brain, analyses certain aspects of a system to detennine the behavioural consequence
of an action. There is evidence to suggest the autistic brain is a highly masculinised
systemising brain with an impairment in empathising. Behaviours such as 'mind
reading' (ability to understand and predict behaviour of others), reading facial
expressions, eye contact, language development and social interaction are all superior
behaviours in females. Males score lower in all such behaviours, with autistic patients
scoring even lower (Baron-Cohen, 2002).

Some individuals with Asperger syndrome or high functioning autism have special
abilities in mathematical calculations, music and memory of statistics and numbers,
all of which are characteristics of a systemising brain common in males. Attention to
detail, preference for factual and structured information, collecting and organising
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objects as well as hobbies such as train spotting due to the structured fonnatted
timetables are all common in autistic individuals as well as being characteristic of a
systemising male brain (Baron-Cohen, 2002).

Due to a lack of gender based studies on autism, a definitive answer can not be made
with regard to sexually dimorphic brain structures in accounting for the difference in
male-female prevalence rates. Several structures such as the amygdala, hippocampus,
cerebe~lum

and cerebrum have all been implicated in the pathogenesis of autism

(Herbert, 2005; Schumann et al, 2004). Macroencephaly occurs in 20% of autistic
children compared to 3% of the normal population (Dementieva et al, 2005; Deutsch
et al, 2003). This enlargement of the brain appears to be apparent in children yet is not
maintained in adulthood (Aylward et al, 2002; Curchesne et al, 2001). Further
research is needed on the gender differences in autism to create a better understanding
of the disease and its development. A male-female prevalence ratio of 4:1 is a
significant difference and the reason for this should be ascertained (Stone et al, 2004).

6.4 Parkinson's Disease

This neurological disease is between 2 and 3 times more common in males than
females (Baldereschi et al, 2000; Bower et al, 1999; Czlonkowska et al, 2005;
Milanov et al, 2001; Van Den Eeden et al, 2003). Parkinson's disease (PD) is
characterised by selective degeneration of dopamine neurons within the substantia
nigra pars compacta producing a decrease in dopamine levels and a loss of
neuromelanin (the dark pigmentation found in dopaminergic neurons) as seen m
Figure 10 (Fahn et al, 2004). The substantia nigra inhibits the function of the cerebral
nuclei with the release of dopamine. A decrease in dopamine production causes the
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cerebral nuclei to become overactive, producing an increase in muscle tone and other
characteristic symptoms of Parkinson's disease such as stooped posture, slowed
voluntary movements, rigidity and muscle tremors (Cotran et al, 1999).

Figure 10- Midbrain section of the substantia nigra showing the loss ofpigmentation
in Parkinson 's disease (WebPath,2006).

An accepted theory behind the lower prevalence of PD in females

IS

agam the

neuroprotective role of oestrogen. Studies in which rodents were treated with
neurotoxins

such

as

6-hydroxydopamine

or

1-methyl-4-phenyl-1,2,3,6

tetrahydropyridine (MPTP) and subsequently treated with oestrogen showed a
decrease in dopaminergic neuron loss (Czlonkowska et al, 2005). Females are
reported to have greater dopamine neuronal density within the caudate nucleus which
could be another explanation as to why females do not develop PD as often and as
severely (Becker, 1999; Walker et al, 2000).

46

Numerous studies have reported increased cytokine levels within cerebrospinal fluid
and the striatum of Parkinson's patients (Czlonkowska et al, 2005; Hunot et al, 1997;
Le et al, 1999). Pro-inflammatory cytokines such as interferon-gamma (IFN-y),
interleukin-1 beta

(IL-l~)

and tumour necrosis factor-alpha (TNF-a) are evident

within the striatum of PD patients, suggesting a role of the inflammatory response in
the pathogenesis of Parkinson's disease (Nagatsu et al, 2000; Nagatsu, 2002).
Evidence from oestrogen studies have shown that it decreases production of certain
cytokines such as

IL-l~,

TNF-a as well as interleukin-6 (IL-6) and that these pro-

inflammatory cytokines also increase after menopause or if oestrogen levels are
reduced (Bemard-Poenaru et al, 2001; Cantatore et al, 1995; Rogers et al, 2001).

The dopaminergic toxin MPTP (1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine) has
also been used to establish inflammatory responses within the CNS. Mice injected
with the toxin exhibited an increase in the pro-inflammatory cytokine TNF-a within
the striatum yet there was a higher expression of this factor in the male mice than the
female. TNF -a was found 6 hours after administration of MPTP whereas it took 1 day
for the protein to be located within female mice (Cesielska et al, 2003). TNF- a is a
powerful neurotoxin and may initiate and sustain the inflammatory response in
Parkinson's disease leading to degeneration of dopaminergic neurons (Czlonkowska
et al, 2005).

The majority of Parkinson's cases occur sporadically with unknown causes yet 10%
of cases are said to be familial (Falm et al, 2004). The SRY gene found on the Y
chromosome has recently been reported to influence the production of dopamine in
the substantia nigra. Studies in which the SRY gene was deleted from one side of the
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substantia nigra in male mice showed that in that portion, there was a 38% decrease in
dopaminergic neurons. These mice also exhibited Parkinson's like motor functions in
the one side controlled by the substantia nigra that had been altered (Gramling, 2006).

6.5 Cardiovascular Disease

In general, premenopausal females appear to have a lower prevalence of
cardiovascular disease and show a better prognosis than males. Between the ages of
45 and-64, 39% more males die from heart disease than females yet after 65 years of
age, the rate of death for women exceeds that of males by 22% (Leinwand, 2003). The
diastolic function of the heart, i.e. the phase in which the chamber fills with blood
preparing for contraction (systole) is more efficient in females than in males. Systolic
function is also superior in females due to increased thickness in the heart wall
(Leinwand, 2003). Men show poorer contractility, myocardial thi1111ing and inferior
chamber dilation when compared to females (Adams et al, 1999; Legget et al, 1996;
Leinwand, 2003).

Hypertension, which is classified as having a constant elevated blood pressure, is
more common in men of 30-45 years than age matched women. Male rats have
greater vascular contraction than female rats and ovariectomised females have a
greater vascular contractility than intact females, suggesting a role of oestrogen in the
physiological control mechanisms of hypertension (Khalil, 2005). Support for this
theory arises from statistics that show postmenopausal women suffer from
hypertension at the same rates as men (Czubryt et al2006; Khalil, 2005).
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Myocardial infarction (MI), in which necrosis of an area within the heart occurs due
to ischaemia, is another cardiovascular disease that occurs in greater numbers in men
than premenopausal women. Atherosclerosis is a common cause of myocardial
infarction yet as this occurs in women much later in life; women experiencing MI's
are also significantly older than males (Czubryt et al, 2006). Although women
experience MI's less often than men, it is reported that young or middle aged women
who suffer aMI have an increased mortality rate compared with men (Czubryt et al,
2006; Naccarino et al, 2000). Stromberg and Martensson (2003) have reported that
myocardial infarctions in women are more severe and heart failure is more likely to
occur as a consequence.

Before puberty the number and size of cardiac cells, or myocytes, are approximately
the same in both genders yet it is reported that the absolute mass of the male heart is
15-30% larger than that of post-pubertal females. This suggests that some hormonal
influence which occurs during puberty causes male myocytes to enlarge producing a
heart of greater mass (Leinwand, 2003).

Although a significant volume of evidence has supported the role of oestrogen in
protecting the cardiovascular system, studies of hormone replacement therapy (HRT)
regimes has suggested otherwise. Post-menopausal women taking oestrogen and
progesterone supplements have shown that these hormones provided no additional
protection against cardiovascular disease, contradicting earlier reports on HRT
(Harman et al, 2005; Manson et al, 2001). Paradoxically HRT has been associated
with an increase in certain cardiovascular disease such as Cerebrovascular Accident
(CVA) commonly known as stroke. A timing hypothesis has been proposed to
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account for the results of HRT that contradict the beneficial results of oestrogen in
pre-menopausal women and to account for the positive results of HRT in previous
studies. It is believed that HRT needs to be administered during or soon after
menopause in order for the hormones to have an effect. A delay in treatment is
thought to allow atherosclerotic lesions to become too advanced for hormone
replacement to have a beneficial effect (Hannan et al, 2005; Mendelsohn et al, 2005).

The U$e of rodents in the study of cardiovascular disease has not been highly
successful as studies have produced conflicting results and are not comparable,
making it difficult to draw appropriate conclusions. Various studies have been
conducted on the papillary muscles of rats, yet the age of the rats and methods for
measurement all differed, making comparisons difficult. The papillary muscles of 6
month old rats had been studied and it was concluded that males had a slower
contraction and relaxation rate. Another study using the papillary muscle of an
isolated working heart preparation concluded that males had an increased cardiac
output. Experiments on rats younger than 6 months old produced no varying
differences in the cardiovascular system between genders. It is clear that experiments
need to be conducted in a systematic manner, using the same strain of rodent, the
same sampling technique and rats of the same age, in order to reach suitable
conclusions (Leinwand, 2003).

The age of the rodents at the time of cardiovascular testing is especially important if
the results are to be compared with the human cardiovascular system. As shown by
Leinwand (2003), complete sexual differentiation of the human cardiovascular system
may not occur until adulthood. In rodents the comparable age would be 10 to 12
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months yet most studies are performed when the rodent is 6 months of age or
younger, which may explain why experiments have produced results that have
indicated no sexual differentiation in heart structure or function.

6.6 Alzheimer's Disease
This neurodegenerative disease is the leading cause of dementia worldwide,
characterised by extracellular deposition of amyloid plaques and the presence of
intracellular neurofibrillary tangles (NFTs) within the brain (Bates, 2005; Gandy,
2005; Spires et al, 2005). Memory loss is the first symptom of Alzheimer's disease,
followed by a decline in all cognitive abilities. In the end stage of the disease, motor
functions are affected and patients become bedridden (Spires et al, 2005).

The formation of amyloid plaques mainly occurs within the hippocampus, neocortex
and amygdala of affected individuals. Neurofibrillary tangles (NFTs) are found within
the hippocampus, neocortex, amygdala and within several thalamic and hypothalamic
nuclei. The degree of neuronal loss within the brain is directly correlated with the
extent of NFT formation. In the end stages of the disease approximately 90% of
prefrontal cortex neurons have died and 70% of the neurons within the hippocampus
suffer the same fate, causing the severe dementia seen in Alzheimer's patients (Spires
et al, 2005).

Although a majority of Alzheimer's cases are sporadic, approximately 1% of cases
occur due to an autosomal dominant inheritance. The first gene associated with
Alzheimer's disease was found in the amyloid precursor protein (APP) gene yet
genetic linkage studies have discovered mutations in the presenilin 1 and 2 genes on
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chromosome 14 and 1 respectively. The presenilin genes are involved in the
production of amyloid

~

by forming the active site of the y-secretase complex that in

tum cleaves the amyloid precursor protein. Once APP is cleaved it forms the amyloid
~

that aggregates to form the characteristic plaques of Alzheimer's disease (Spires et

al, 2005).

Oestrogens have a profound role within the central nervous system in protecting
neuronal cells. Some studies of oestrogen replacement therapy and Alzheimer's
disease have shown that oestrogen decreases the presence of amyloid

~'

in tum

decreasing plaque development. In vivo and in vitro studies have shown that
testosterone increases the presence of amyloid

~

and increases its toxicity within the

hippocampal region of the brain. Once women enter menopause and oestrogen levels
decrease, the neuroprotective role of oestrogen is diminished, which may lead to the
higher prevalence of Alzheimer's seen in women (Bates et al, 2005).

Two major cholinergic nuclei within the basal forebrain, the vertical limb of the
diagonal band of Broca (VDB) and the nucleus basalis of Meynert (NBM), have been
implicated in the pathology of Alzheimer's. The cholinergic neurons within these
nuclei are significantly decreased in male and female Alzheimer patients. As memory
and other cognitive functions are a main role of the cholinergic system, it is believed
that this decrease in neurons causes many of the symptoms seen in Alzheimer's
disease (Ishunina et al, 2002). Within humans (Donahue et al, 2000; Ishunina and
Swaab, 2001), and animals (Ishunina et al, 2002; Mufson et al, 1999), the function of
the cholinergic neurons is largely influenced by sex hormones. The number of
androgen receptors within the VDB and NBM are significantly lower in female
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Alzheimer patients as opposed to males, which may account for the increased risk of
Alzheimer's in females (Ishunina et al, 2002).

In general, studies report a higher incidence and prevalence rate of Alzheimer's
disease in women (Bonsignore et al, 2002; Yue et al, 2005) yet when examined
closely, several variables have not been accounted for. There are a variety of
explanations that may account for the inconsistencies in research results with regard
to disease incidence and prevalence between genders. The fact that females are known
to survive longer than males and are therefore more susceptible to diseases associated
with ageing is an important variable that needs to be assessed when reporting data.
Females with Alzheimer's disease are reported to survive longer compared to males,
therefore there may be more females alive to participate in studies than there are
males. These two factors produce a selection bias due to the under-representation of
males within Alzheimer's disease studies (Bonsignore et al, 2002).
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CHAPTER SEVEN

Methods

This literature review involved the analysis of journal articles that were accessed
through the Edith Cowan University online database collection. Numerous databases
were scrutinised to ensure this review was based on the latest and most current
information regarding this topic. The main database engines used for this study were:

•

Biomed Central

•

Pubmed Central

•

Pro Quest

•

Oxford Journals

•

Science Direct

•

Ovid Online

•

Google

Other databases such as BMJ Journals Online and Cochrane were excluded from this
study as initial searches were unproductive in relation to this topic. All journal articles
used in this study were chosen for their relevance to sex determination, sex
differentiation, sex abnormalities, brain structure between genders or gender-related
diseases. The date of publication was a critical element when choosing articles for
inclusion in this review as the topic is continually progressing. Papers from 2006 were
initially reviewed but few existed so it was necessary to widen the search between the
years 2000 and 2006. Reference lists from relevant journal articles were investigated
and used to collaborate results of current studies.
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The search tenns used that produced the most useful articles included: sex
determination, sex differentiation, SRY gene, SOX9 gene, SF-1 gene, WT-1 gene,
DMRTl gene, GATA4 gene, DAX-1 gene, sex abnormalities, hermaphrodites
testicular feminization, androgen insensitivity syndrome, Congenital Adrenal
Hyperplasia, 21 Hydroxylase Deficiency,

17~-Hydroxysteroid

Dehydrogenase 3

Deficiency, brain sex, brain structure and gender, brain differentiation, hypothalamus
and gender, amygdala and gender, corpus callosum and gender, cerebral cortex and
gender•; brain structure and hormones, Schizophrenia and gender, Alzheimer's and
gender, Autism and gender, Autoimmune disease and gender, sexually dimorphic
disease.
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CHAPTER EIGHT

Results

8.1 Cerebral Cortex

Males have a greater volume and weight of the cerebral cortex than females, with a
neuronal density that is 15% higher (Reiss et al, 1996; De Courten-Myers, 1999;
Rabinowicz et al, 2002; Witelson et al, 2006). White matter volumes are on average
larger ,in males and grey matter volumes are larger in females (De Comien-Myers,
1999). The female cerebral cortex has been found to consist of more neuropil than
males, producing more cell to cell connections and a more extensive dendritic
network (Rabinowicz et al, 1998). Activation of the ventromedial prefrontal cortex
also differs between males and females. Males tend to use the right hemisphere of the
ventromedial cmiex for emotional processing and decision making, whereas females
use the left hemisphere (Tranel et al, 2005).

8.2 Corpus Callosum

The literature regarding sexual dimorphism of the corpus callosum is controversial
but the majority of studies agree that the corpus callosum is larger in females and of a
more spherical shape than that of the male as seen in Table 4 (De Lacoste-Utamsing
et al, 1982; Rabinowicz et al, 2002; Smith, 2005). This increase in fibres connecting
the two hemispheres is one theory underlying the bilateralisation of the female brain
(Rabinowicz et al, 2002).
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8.3 Hypothalamus

There are several nuclei that are sexually dimorphic within the hypothalamus (Swaab
et al, 2003). The preoptic area of the anterior hypothalamus contains four nuclei, the
lateral, medial, median preoptic nuclei and the pariventricular nucleus which are
larger in male brains. The lateral, median and medial preoptic nuclei are 50-70%
larger in males (Table 4). The male lateral preoptic nucleus contains 28% more
neurons whilst the medial preoptic nucleus contains 21% more neurons accounting for
the increase in size. The male medial preoptic nucleus contains 80% more neurons
due to the highly sexually dimorphic nucleus within this region (Madeira et al, 1999).

The sexually dimorphic nucleus (SDN) of the medial preoptic area is 3-8 times larger
in male rats than female rats. The human SDN is approximately twice as large in
young males as females, with twice the number of cells (Gorski et al, 1978; Madeira
et al, 1999; Swaab et al, 1992; Swaab et al, 2003; Von Esenwein et al, 2005). Before
the age of two years, there are no sexual differences in the size or neuronal number of
the sexually dimorphic nucleus (Swaab et al, 2003).

The suprachiasmic nucleus (SCN) of the hypothalamus is larger in the male rat yet in
humans it is only the shape that differs. The female SCN has an elongated shape
whilst the males' is more spherical (Swaab, 1995; Hofman, 1996; Abizaid et al,
2004). In male homosexuals the volume of the SCN is 1.7 times larger with 2.1 times
as many cells as heterosexuals (Swaab et al, 2003).

The Bed Nucleus of the Stria Terminalis (BNST) has two sexually dimorphic regions,
the darkly staining postereomedial component of the BST (BST-dspm) and the central
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division (Allen and Gorski, 1990, Chung et a1, 2002, Garcia-Falgueras, 2005). The
BNST as a whole is larger in males compared to females (Table 4) yet these
differences do not reach significant values until adulthood (Chung et al, 2002).

8.4 Anterior Commissure
The majority of studies report that the anterior commissure is 12% larger in females
than males (Moir and Jessel, 1991; Allen and Gorski, 1992; Swaab and Hofman,
1995).,Some have reported no sexual dimorphism in rat or human studies (Jones et al,
1997; Bishop et al1999; Highley et al, 1999). This structure is only present in 78% of
females and 68% of males (Swaab et al, 2003).

8.5 The Amygdala
This structure is significantly larger in males than females (Goldstein et al, 2001,
Durston et al, 2001, Cahill et al, 2004). Rat studies show that the posterodorsal region
of the medial amygdala is 50-80% larger in males (Cooke et al, 1999), with a larger
number of neurons in the posteromedial region (Rasia-Filho et al, 2000).
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Table 4- Summary of Sexually Dimorphic Brain Structures in Humans.
Study

Reiss et al.

Year

1996

Brain

Sexual

Structure

Dimorphism

Cerebrum

Yes

Size Difference

10% > in human
males

De Courten-Myers.

1999

Cerebrum

Yes

;: : : 10% >in
human males

Rabinowicz et al.

2002

Cerebrum

Yes

15% >inhuman
males

Witelson et al

2006

Cerebrum

Yes

9-12% >in
human males

De Lacoste-Utamsing

1982

et al.
Allen et al.

Corpus

Yes

Callosum
1991

Corpus

>inhuman
females

No

-

Yes

> posterior region

Callosum
Denenberg et al.

1991

Corpus
Callosum

Holloway et al.

1993

Corpus

in human males
No

-

Yes

>in females

Yes

>in females

Callosum
Rabinowizc et al.

2002

Corpus
Callosum

Smith

2005

Corpus
Callosum

Madeira et al

1999

PAOH

Yes

> in human males

Gorski et al.

1978

SDN

Yes

>in males

Swaab et al.

1992

SDN

Yes

>in males

Swaab et al.

2003

SDN

Yes

>in males

Von Esenwein et al

2005

SDN

Yes

>in males

Swaab.

1995

Suprachiasmic

Yes

difference in

Nucleus
Hofman et al.

1996

Suprachiamic
Nucleus

shape
Yes

difference in
shape
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Abizaid et al.

2004

Suprachiasmic

Yes

Nucleus

difference in
shape

Allen et al.

1990

BNST

Yes

>in males

Chung et al.

2000

BNST

Yes

>in males

Chung et al.

2002

BNST

Yes

>in males

Garcia-Falgueras

2005

BNST

Moir and Jessel

1991

Anterior

>in males
Yes

12% >females

Yes

12% >in females

Yes

12% >in females

No

-

No

-

No

-

Commissure
Allen and Gorski

1992

Commissure

:/

Swaab and Hofman

Anterior

1995

Anterior
Commissure

Jones et al.

1997

Anterior
Commissure

Bishop et al.

1999

Anterior
Commissure

Highley et al.

1999

Anterior
Commissure

Goldstein et al.

2001

Amygdala

Yes

>in males

Durston et al.

2001

Amygdala

Yes

>in males

Cahill et al.

2004

Amygdala

Yes

>in males

PAOH =Preoptic Area ofthe Hypothalamus
SDN =Sexually Dimorphic Nucleus of the Hypothalamus
BNST =Bed Nucleus of the Stria Tenninalis

60

CHAPTER NINE

Discussion
Although there are a number of brain structures that are universally accepted as being
sexually dimorphic, various studies report no significant differences in structure or no
con-elating function to such differences. Cerebral size has been found to be larger in
males (De Courten-Myers, 1999; Rabinowicz et al, 2002; Reiss et al, 1996; Witelson
et al, 2006) yet this does not produce a con-esponding increase in intelligence or
higher function of the cerebral cortex in men. The corpus callosum and anterior
commissure are bundles of nerve fibres that connect the two cerebral hemispheres.
These fibre networks are larger in females and are directly con-elated with an increase
in cerebral function (Denenberg et al, 1991; Rabinowicz et al, 2002; Smith, 2005).
The larger interhemispheric connection in females is believed to contribute to the
bilateralisation of the female brain (Rabinowicz et al, 2002) and may be a factor
behind the decreased prevalence and severity associated with diseases such as
schizophrenia, mental retardation and stroke.

Observations of the nuclei within the hypothalamus have consistently reported sexual
dimorphism with regard to size of ce1iain nuclei. The preoptic area of the
hypothalamus (Madeira et al, 1999), the sexually dimorphic nucleus (Gorski et al,
1978; Swaab et al, 1992; Swaab et al, 2003; Von Esenwein et al, 2005),

suprachiasmic nucleus (Abizaid et al, 2004; Hofman et al, 1996) and the bed nucleus
of the stria terminalis (Allen et al, 1990; Chung et al 2000; Chung et al, 2002; GarciaFalgueras, 2005) have been identified as being larger in males as opposed to females.
The most significant sexual dimorphism has been found within the sexually
dimorphic nucleus (SDN). This structure is almost twice as large within human adult
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males and 3-8 times larger in the male adult rat. The function of the SDN has been
associated with sexual behaviour and identity within both sexes yet the larger nucleus
in males is thought to cause a corresponding increase in sexual appetitive behaviour
common to the male sex (Swaab et al, 2003).

The amygdala, which is involved in emotional processing, memory, fear responses
and reproductive behaviour, is significantly larger in both human and rat males
(Hamann, 2005). PET imaging has revealed that the male amygdala is stimulated to a
higher degree with regard to arousing material and is also linked to the increased
sexual appetitive behaviour exhibited by the male gender (Hamman et al, 2005). A
variety of sexual disorders, all of which are more common in males, have been linked
to an abnormality within the amygdala (Gomez, 1991). Lesions within the amygdala
support the role of the amygdala in abnormal sexual behaviours as these individuals
exhibit a failure to recognise social norms in regards to sexual behaviour and are
prone to a range of paraphilia's such as voyeurism, exhibitionism, paedophilia and
fetishism (Bezeau et al; 2004; Kafka et al, 2002).

The presence of sex differences in morbidity and mortality rates are clear as seen in
this present study (Bren, 2005; Gesensway, 2001; Pi1111, 2003; Rieker et al, 2005;
Wizema1111 et al, 2001). However the mechanism(s) behind these differences needs
more thorough research. Sex hormones play an important role in sex differentiation
both in development and throughout life, forming a basis behind the sexually
dimorphic disease patterns that are becoming evident (Rieker et al, 2005; Wizema1111
et al, 200 1). The significance of hormone production and maintenance can be shown
through sex differentiation abnormalities in which the lack of a hormone or its loss of
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function can produce devastating effects (Witchel, 2002) such as testicular
feminisation (Holterhus et al, 2003) and congenital adrenal hyperplasia (Merke and
Bomstein, 2005).

Prima1y hermaphrodites arise due to a mutation which causes an individual to be born
with internal and/or external genitalia of both sexes. Due to ambiguous external
genitalia, individuals may not be raised according to their chromosomal sex. Once
puberty arises, these individuals begin to think according to the sex of their brain and
not necessarily their external genitalia, causing serious mental anguish and identity
problems (Salas-Cortes et al, 2000). Testicular feminisation is an example of a
secondary hem1aphrodite that arises due to abnormal androgen receptors. These
individuals exhibit ambiguous genitalia as well as feminisation, both of which are
directly correlated with the degree of androgen receptor function (Holterhus et al,
2003).

Although it is evident that many sex differences are due to the action of hormones, it
is unlikely they are the sole cause. There are genes located on the X chromosome that
are expressed at increased levels within females despite X chromosome activation.
Genes that are located on theY chromosome, such as the SRY gene, may also play a
role in sexual dimorphism leading to differences in the central nervous system and
affecting disease patterns (Leinwand, 2003).

From conception, it appears males are disadvantaged with a greater risk of brain
damage, congenital deformities, still birth and cerebral palsy. After birth,
developmental disorders such as autism, attention deficit hyperactivity disorder and
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stuttering are all more common in males (Hertz-Picciotto, 2006; Kraemer, 2000;
Powell, 2004; Stone et al, 2004), as well as other diseases such as schizophrenia (Cyr
et al, 2002), cardiovascular disease (Leinwand, 2003) and Parkinson's disease
(Czlonkowska et al, 2005). Although a majority of diseases appear to be more
common in males, there are some diseases more prevalent in females such as
autoimmune diseases (Rubin, 2001) and Alzheimer's disease (Ott et al, 2001).

This study has shown that females fare better in terms of prevalence and severity of
numerous diseases due to the neuroprotective role of oestrogen. Evidence to support
the role of oestrogen arises through oestrogen knockout mice and human studies in
which the incidence of disease increases for females once they have reached
menopause and a corresponding decrease in oestrogen occurs (Hafner et al, 2003;
Khalil, 2005; Rogers et al, 2001).

Researchers have recognised that the majority of organs within the body, not just
those of the reproductive system, are sexually dimorphic in structure and in some
cases function (Kraemer, 2000). These dimorphisms lead to a different prevalence of
disease states, different symptoms and different pharmacological treatments. Females
and males differ in regards to drug absorption, distribution and excretion. Therefore
studies on drug treatments need to use gender as an important variable in their
analysis that must be accounted for (Bren, 2005).

A majority of research has failed to produce data on females and males as a separate
population despite the evidence that females and males differ significantly in normal
physiology and pathological functions. In 2001, the Institute of Medicine published a
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report concerning gender differences in medicine and the importance of gender
related studies (Wizemann et al, 2001). Since this report, the number of studies that
include sex as a variable have dramatically increased providing a better understanding
of the basis behind certain mechanisms and disease pathologies. The report also states
that journals should encourage authors to publish sex related data, whether it be of
significance or not, in order to create a better understanding of sex differences
(Kreeger, 2002).

The approach to companng males and females, whether it be anatomical or
physiological, is in need of more efficient study parameters. The knowledge of the
test subject's biology as well as the environment in which the study is occurring are
important factors when studying sex related differences. As sex steroids can have a
dramatic affect on sexually dimorphic traits it is not sufficient to measure females at
random times within the ovarian cycle. Comparing males with two or more groups of
females where the oestrous cycle is known would show whether males and females
differ in a certain trait and at what time of the ovarian cycle the differentiation occurs.
Sex differences may be overlooked in simple studies consisting of one male and one
female group, as certain traits may only differ at certain times of the oestrous cycle. If
. tested at the wrong time of the oestrous cycle, sex differences may not be seen,
therefore producing negative results (Becker et al, 2005).

An individual's sex does not just determine their physical appearance but can
influence their cognitive abilities, behaviour and all aspects of disease ranging from
susceptibility, to drug treatments. It is for these reasons that research on normal
structure and functioning as well as disease states should include sex as a key
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variable, therefore producing data on both genders instead of males and females being
included in the same category (Wizemann et al, 2001). This study has concluded there
are several sexual dimorphic stmctures within the brain as well as the reproductive
system, and that many disease states differ with regard to prevalence and severity
between genders. It is clear that males are no longer the superior sex but rather just
one half of the bigger picture.

66

LITERATURE CITED

Abizaid, A., Mezei, G., Sotonyi, P., Horvath, T. (2004). Sex differences in adult
suprachiasmatic nucleus neurons emerging late prenatally in rats. European
Journal ofNeuroscience, 19, p2488-2496.

Adams, K., Sveta, C., Gheorghiade, M., O'Connor, C., Schwartz, T., Kock, G.,
Uretsky, B., Swedberg, K., Me Kenna, W., Soler-Soler, J., Califf, R. (1999) .
. Gender differences in survival in advanced heart failure. Insights from the
'

FIRST study. Circulation, 99, p1816-1821.

Ahmed, S., Hissong, B., Verthelyi, D., Donner, K., Becker, K., Karpuzoglu-Sahin.
(1999). Gender and Risk of Autoimmune Disease: Possible Role of Estrogenic
Compounds. Environmental Health Perspectives Supplements, 107, (S5), p15.

Allen, L., Gorski, R. (1990). Sex difference in the bed nucleus of the stria terminalis
ofthe human brain. Journal ofComparative Neurology, 302, p697-706.

Allen, L., Richey, M., Chai, Y., Gorski, R. (1991). Sex Differences in the corpus
callosum of the living human being. Journal ofNeuroscience, 11, p933-942.

Allen, L., Gorski, R. (1992). Sexual orientation and the size of the anterior
commissure in the human brain. Proceedings of the National Academy of
Sciences in the Unites States of America, 89, p7199-7202.

American Psychiatric Association. (1994). Diagnostic and Statistical Manual of
Mental

Disorders,

(4th

ed).

Washington

DC:

American

Psychiatric

Association.

67

Angermeyer, M., Kuhn, L. (1988). Gender differences in age at onset of
schizophrenia. European Archives of Psychiatry and Neurological Science,
237, p351-364.

Ansar Ahmed, S., Hissong, B., Be1ihelyi, D., Donner, K., Becker, K., KarpuzogluSahin, E. (1999). Linking Environmental Agents and Autoimmune Diseases.
Environmental Health Perspectives Supplements, 107, (S5), p 681-686.

Aylward, E., Minshew, N., Field, K., Sparks, B., Singh, N. (2002). Effects of age on

,. brain volume and head circumference in autism. Neurology, 59, p175-183.
Baldereschi, M., DiCarlo, A., Rocca, W., Vanni, P., Maggi, S., Perisinotto, E.,
Grigoletto, F., Amaducci, L., Inzitari, D. (2000). Parkinson's disease and
parkinsonism in a longitudinal study: two fold higher incidence in men.
Neurology, 55, p1358-1363.

Bates, K., Harvey, A., Carrithers, M., Martins, R. (2005). Androgens, andropause
and neurodegeneration: exploring the link between steroidogenesis, androgens
and Alzheimer's disease. Cellular and Molecular Life Sciences, 62, p281-292.

Baron-Cohen, S. (2002). The extreme male brain theory of autism. Trends in
Cognitive Sciences, 6, (6), p248-254.

Bear, M., Connors, B., Paradiso, M. (2001). Neuroscience Exploring The Brain. USA:
Lippincott Williams and Wilkins.

Becker, J. (1999). Gender differences in dopaminergic function in striatum and
nucleus accumbens. Pharmacology Biochemist1y and Behaviour, 64, p803812.

Becker, J., Arnold, A., Berkley, K., Blaustein, J., Eckel, L., Hampson, E., Herman, J.,
Malis, S., Sadee, W., Steiner, M., Taylor, J., Young, E. (2005). Strategies and
Methods for Research on Sex Differences in Brain and Behaviour.
Endocrinology, 146, (4), p1650-1673.
68

Bermudez, P and Zatorre, R. (2001). Sexual Dimorphism in the Corpus Callosum:
Methodological Considerations in MRI Morphometry. Neuroimage, 13,
p1121-1130

Bemard-Poenaru, 0., Roux, C., Blanque, R., Gardner, C., de Vemejoul, M., CohenSola!, M. (2001). Bone-reabsorbing cytokines from peripheral blood
mononuclear cells after hormone replacement therapy: a longitudinal study.
Osteoporosis International, 12, p769-776._

Bezeau,
,. S., Bogod, N., Madeer. (2004). Sexually intrusive behaviour following brain
injury: approaches to assessment and rehabilitation. Brain Injury, 18, (3),
p299-313.

Bishop, K., Wahlsten, D. (1999). Sex and species differences in mouse and rat
forebrain commissures depend on the method for adjusting for brain size.
Brain Research, 815, p359-366.

Bonsignore, M., Barkow, K., Heun, R. (2002). Possible influence of selection bias on
gender differences in the risk of Alzheimer's disease. Archives of Women's
Health, 5, p73-77.

Bower, J., Maraganore, D., McDonell, S., Rocca, W. (1999). Incidence and
distribution of parkinsonism in Olmstead County, Mi1111esota, 1970-1990.
Neurology, 52, p1214-1220.

Bren, L. (2005). Does Sex Make a Difference. FDA Consumer, 39, (4), p10-15.

Bryant, N., Buchanan, R., Vladar, K., Breier, A., Rothman, M. (1999). Gender
Differences in Temporal Lobe Structures: A Volumetric MRI Study.
American Journal of Psychiatry, 156, (4), 603-609.

Caleb. N., Gearhart, J. (2004). Current views on evaluation, management, and gender
assignment of the intersex infant. Nature Clinical Practice Urology, 1, p38-43.

69

Cahill, L., Haier, R., Fallon, J., Alkire, M., Tang, C., Keator, D., Wu, J., McGaugh, J.
(1996). Amygdala activity at encoding conelated with long-term free recall of
emotional information. Proceedings of the National Academy of Sciences of
the United States of America, 93, p8016-8021.

Cahill, L., Haier, R., White, N., Fallon, J.,Kilpatrick, L., Lawrence, C., Potkins, S.,
Alkire, M. (2001). Sex related differences in amygdala activity during
emotionally influenced memory storage. The Neurobiology of Learning and
Memory, 75, p1-9.

Cahill, L., Uncapher, M., Kilpatrick, L., Alkire, M., Turner, J. (2004). Sex-Related
Hemispheric Lateralisation of Amygdala Function in Emotionally Influenced
Memory: an fMRI Investigation. Learning and Memory, 11, p261-266.

Canli, T., Desmond, J., Zhao, Z., Gabrieli, J. (2002). Sex differences in the basis of
emotional memories. Proceedings of the National Academy of Sciences of the
United States of America, 99, (16), p10789-10794.

Cantatore, F., Loveno, G., Ingrosso, A., Lacanna, R., Sassanelli, E., Selvaggi, L.
(2001). Effect of oestrogen replacement on bone metabolism and cytokines in
surgical menopause. Clinical Rheumatology, 14, p157-160.

Cesielska, A., Jones, I., Przybylkowski, A., Gromadzka, G., Czlonkowska, A.,
Czlonkowski, A. (2003). The influence of age and gender on the TNF-a
mRNA expression in murine model Parkinson's disease. Journal of
Neurology, 250, (S2), p II/140.

Chung, W., De Vries, G., Swaab, D. (2002). Sexual Differentiation of the Bed
Nucleus of the Stria Terminalis in Humans May extend into Adulthood.
Journal ofNeuroscience, 22, (3), p1027-1033.

Chung, W., Swaab, D., De Vries, G. (2000). Apoptosis during Sexual Differentiation
Of the Bed Nucleus of the Stria Terminalis in the Rat Brain. Journal of
Neurobiology, 43, (3), p234-243.
70

Cooke, B., Tabinia, G., Breedlove, M. (1999). A brain sexual dimorphism controlled
by adult circulating androgens. Proceedings of the National Academy of
Sciences of the United States of America, 96, (13), p7538-7540.

Cotran, R., Kumar, V., Collins, T. (1999). Pathologic Basis of Disease (6thed). USA:
W.B Saunders Company.

Courchesne, E., Karns, C., Davis, H., Ziccardi, R., Carper, R., Tigue, Z. (2001).
Unusual brain growth patterns in early life in patients with autistic disorder: an
MRI study. Neurology, 57, p245-254.

Crawford, P., Dorn, C., Sadovsky, Y, Milbrandt, J. (1998). Nuclear receptor DAXl
recmits nuclear receptor corepressor N-CoR to steroidogenic factor 1.
Molecular and Cellular Biology, 18, p2949-2956.

Cyr, M., Calon, F., Morisette, M., DiPaolo, T. (2002). Estrogenic modulation of
brain activity: implications for schizophrenia and Parkinson's disease. Journal
of Psychiatry and Neuroscience, 27, (1), pl2-27.

Czlonkowska, A., Ciesielska, A., Gromadzka, G., Kurkowska-Jastrzebska. (2005).
Estrogen and Cytokines Production -

The Possible Cause of Gender

Differences in Neurological Diseases. Cunent Pharmaceutical Design, 11, (8),
pl017-1030.

Czybryt, M., Espira, L., Lamoureux, L., Abrenica, B. (2006). The role of sex in
cardiac function

and disease.

Canadian Journal

of Physiology and

Pharmacology, 84, (1 ), p93-1 09.

De Courten-Myers, G. (1999). The Human Cerebral Cortex: Gender Differences in
Stmcture and Function. Journal of Neuropathy and Experimental Neurology,
58, (3), p217-226.

De Lacoste-Utamsing, C., Holloway, R. (1982). Sexual dimorphism in the human
corpus callosum. Science, 216, p 1431-1432.
71

Dementieva, Y., Vance, D., Donelly, S., Elston, L., Wolpert, C., Ravan, S. (2005).
Accelerated head growth in early development of individuals with autism.
Paediatric Neurology, 32, pl02-108.

Denenberg, V., Kertesz, A., Cowell, P. (1991). A factor analysis of the human's
corpus callosum. Brain Research, 548, p126-132.

Deutsch, C., Joseph, R. (2003). Briefrepmi: cognitive con-elates of enlarged head
circumference in children with autism. Journal of Autism and Developmental
Disorders, 33, p209-215.

De Vries, G. (2004). Minireview: Sex Differences in Adult and Developing Brains:
Compensation, Compensation, Compensation. Endocrinology, 145, (3),
p1063-1068.

Donahue, J., Stopa, E., Chorsky, R., King, J., Schipper, H., Tobet, S., Blaustein, J.,
Reichlin, S. (2000). Cells containing immunoreactive estrogen receptor-alpha
in the human basal forebrain. Brain Research, 856, p142-151.

Durston, S., HulshoffPol, H., Casey, B., Giedd, J., Buitelaar, J., Van Engeland, H.
(2001). Anatomical MRI of the developing human brain: What have we
learned?. Journal of the American Academy of Child and Adolescent
Psychiatry, 40, p1012-1020.

Falm, S., Sulzer, D. (2004). Neurodegeneration and Neuroprotection in Parkinson's
Disease.

The

Journal

of the

American

Society

for

Experimental

NeuroTherapeutics, 1, p139-154.

Fink, G., Sumner, B., McQueen, J., Wilson, H., Rose, R. (1998). Sex steroid control
of mood, mental state and memory. Clinical and Experimental Pharmacology
and Physiology 25, p764- 765.

72

Frederikse, M., Lu, A., Aylward, E., Barta, P., Shanna, T., Pearlson, G. (2000). Sex
Differences in Inferior Parietal Lobule Volume in Schizophrenia. The
American Journal of Psychiatry, 157, (3), p422-427.

Gaillard, R., Spinedi, E. (1998). Sex- and stress-steroids interactions and the immune
system: Evidence for a neuroendocrine-immunological sexual dimorphism.
Domestic Animal Endocrinology, 15, p345-352.

Gandy, S. (2005). The role of cerebral amyloid

~

accumulation in common forn1s of

,. Alzheimer's Disease. The Journal of Clinical Investigation, 115, (5), p11211129.

Garcia-Falgueras, A., Pinos, H., Collado, P., Pasaro, E., Fernandez, R., Segovia, S.,
Guillamon, A. (2005). The expression ofbrain sexual dimorphism in artificial
selection ofrat strains. Brain Research, 1052, p130-138.

Gasca, S., Canizares, J., de Santa Barbara, P., Mejean, C., Poulat, F., Berta, P.,
Boizet-Bonhoure, B. (2002). A nuclear export signal within the high mobility
group domain regulates the nucleoplasmic translocation of SOX9 during
sexual determination. Proceedings of the National Academy of Sciences of the
United States of America, 99, (17), p11199-11204.

Gesensway, D. (2001). Reasons for Sex-Specific and Gender-Specific Study of
Health Topics. Annals of Internal Medicine, 135, (10), p935-938.

Gillberg, C., Wing, L. (1999). Autism: not an extremely rare disorder. Acta
Psychiatrica Scandinavica, 99, (6), p399-406.

Goldstein, J., Seidman, L., Horton, N., Makris, N., Kennedy, D., Caviness Jr, V.,
Faraone, S., Tsuang, M. (2001). Normal sexual dimorphism of the adult brain
assessed by in vivo magnetic resonance imaging. Cerebral cortex, 11, p490497.

73

Gomez, J. (1991). Psychological and psychiatric problems in men. New York:
Routledge.

Good, C., Johnsrude, 1., Ashburner, J., Henson, R., Friston, K., Frackowiak, R.
(2001). Cerebral Asymmetry and the Effects of Sex and Handedness on Brain
Structure: A Voxel-Based Morphometric Analysis of 465 Norn1al Adult
Human Brains. Neuroimage, 14, p685-700.

Goodfellow, P., Lovell-Badge, R. (1993). SRY and sex determination in mammals.
,. Annual Review of Genetics, 27, p71-93.

Gorski, R., Gordan, J., Shryne, J., Southam, A.(1978). Evidence for a morphological
difference within the medial preoptic area of the rat brain. Brain Research,
148, p336-346.

Goto, M., Hanley, K., Marcos, J., Wood., J., Wright, S., Postle, A., Cameron, 1.,
Mason, J., Wilson, D., Hanley, A. (2006). In humans, early cortisol
biosynthesis provides a mechanism to safeguard female sexual development.
Journal of Clinical Investigation, 116, (4), p 953-960.

Gramling, C. (2006). Gender Gap. Science News, 169, (9), p132-134.

Graves, F. (2006). The role of androgen and estrogen receptors in female rhesus
monkey behaviour. Emory University, 116 pages.

Gur, R.C, Turetsky, B., Matsui, M., Yan, M., Bilker, W., Hughett, P, Gur, R.E.
(1999). Sex Differences in Brain Gray and White Matter in Healthy Young
Adults:

Correlations

with

Cognitive

Performance.

The

of

Journal

Neuroscience, 19, (10), p1065-4072.

Hadjiathanasiou, C., Brauner, R., Lortatjacob S., Nivot, S., Jaubert, F., Fellous, M.,
Nihoul-Fekete, C and Rappaport, R. (1994). True Hermaphroditism- Genetic
Variants and Clinical Management. Journal of Paediatrics, 125, (5), p738-744.

74

Hafner, H. (2003). Gender differences in schizophrenia. Psychoneuroendocrinology,
28, p17-54.

Hafuer, H., Behrens, S., De Vry, J., Gattaz, W. (1991). Oestradiol enhances the
vulnerability threshold for schizophrenia in women by an early effect on
dopaminergic neurotransmission. Evidence from an epidemiological study and
from animal experiments. European Archives of Psychiatry and Clinical
Neuroscience, 241, p65-68.

Hamann,
,. S. (2005). Sex Differences in the Response of the Human Amygdala. The
Neuroscientist, 11, (4), p288-294.

Harley, V., Layfield, S., Mitchell, C., Forwood, J., John, A., Briggs, L., McDowall,
S., Jans, D. (2003) Defective importin

Brecognition and nuclear import of the

sex-determining factor SRY are associated with XY sex-reversing mutations.
Proceedings of the National Academy of Sciences of the United States of
America, 100. (12), p7045-7050.

Harman, S., Brinton, E., Cedars, M., Lobo, R., Manson, J., Merriam, G. (2005).
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric, 8, p3-12.

Herbert, M. (2005). Large Brains in Autism: the Challenge of Pervasive Abnormality.
The Neuroscientist, 11, (5), p41 7-440.

Hertz-Picciotto, I., Croen, L., Hansen, R., Jones, C., Van de Water, J., Pessah, I.
(2006). The CHARGE Study: An Epidemiologic Investigation of Genetic and
Environmental Factors Contributing to Autism. Environmental Health
Perspectives, 114, (7), p1119-1125.

Highley, J., Esiri, M., McDonald, B., Roberts, H., Walker, M., Crow, T. (1999). The
size and fiber composition of the anterior commissure with respect to gender
and schizophrenia. Biology ofPsychiatry, 45, p1120-1127.

75

Hofman, M., Zhou, J., Swaab, D. (1996). Suprachiasmic nucleus of the human brain:
an immunocytochemical and morphometric analysis. The Anatomical Record,
244, p552-562.

Holterhus, P., Hiort, 0., Demeter, J., Brown, P., Brooks, D. (2003). Differential gene
expression pattems in genital fibroblasts of normal males and 46,XY females
with androgen insensitivity syndrome: evidence for early programming
involving the androgen receptor. Genome Biology, 4, ( 6), R3 7.

Hooloway, R., Anderson, P., Defendini, R., Harper, C. (1993). Sexual dimorphism of
the human corpus callosum from three independent samples. American
Joumal of Physical Anthropology. 92, p481-498.

Hunot, S., Bmgg, B., Ricard, D., Michel, P., Muriel, M., Ruberg, M. (1997). Nuclear
Translocation ofNF-kappaB is increased in dopaminergic neurons of patients
with Parkinson's disease. Proceedings of the National Academy of Sciences of
the United States of America, 94, p7531-7536.

Ishunina, T., Fisser, B., Swaab, D. (2002). Sex Differences in Androgen Receptor
Immunoreactivity in Basal Forebrain Nuclei of Elderly and Alzheimer
Patients. Experimental Neurology, 176, (1), p122-132.

Ishunina, T., Swaab, D. (2001). Increased expression of estrogen receptor a and pin
the nucleus basalis of Meynert in Alzheimer's disease. Neurobiology of
Ageing, 22, p417-426.

Johnson, M., Everitt, B. (2000). Essential Reproduction (5 1h ed). Oxford: Narayana
Press.

Jones, H., Ruscio, M., Keyser, L., Gonzalez, C., Billack, B., Rowe, R., Hancock, C.,
Lambert, K., Kinsley, C. (1997). Prenatal stress alters the size of the rostral
anterior commissure in rats. Brain Research Bulletin, 42, p341-346.

76

Kafka, M., Hennen, J. (2002). A DSM-IV Axis I Comorbidity Study ofMales (n=
120) with Paraphilias and Paraphilia Related Disorders. Sexual Abuse: A
Journal ofResearch and Treatment, 14, (4), p 349-366

Kalthoff, K. (200 1). Analysis of Biological Development (2nd ed). New York:
McGraw-Hill.

Kaplan, R., Szechtman, H., Franco, S., Szechtman, B., Nahmias, C., Garnett, E., List,
S., Cleghorn, J. (1993). Three clinical syndromes of schizophrenia in untreated
subjects: relation to brain glucose activity measured by positron emission
topography (PET). Schizophrenia Research, 11, p47-54.

Keefe, D. (2002). Sex hormones and neural mechanisms. Archives of Sexual
Behaviour, 31, (5), p401-403.

Kluver, W., Bucy, P. (1939). Preliminary analysis of the treatment of the temporal
Lobes in monkeys. Archives ofNeurology and Psychiatry, 42, p979-1000.

Khalil, R. (2005). Sex Hormones as Potential Modulators of Vascular Function in
Hypertension. Hypertension, 46, (2), p249-254.

Kleinjan, D., van Heyningen, V. (2005). Long-Range Control of Gene Expression:
Emerging Mechanisms and Disruption in Disease. American Journal of
Human Genetics, 8, p8-32.

Knower, K., Kelly, S., Harley, V. (2003). Turning on the male- SRY, SOX9 and sex
determination in mammals. Cytogenetic and Genome Research, 101, p185198.

Kraemer, S. (2000). Lessons from everywhere: the fragile male. British Medical
Journal, 321, pl609-1612.

Kreeger, K. (2002). Yes, Biologically Speaking, Sex Does Matter. The Scientist, 16,
(1), p 35-38.
77

Kretschmann, H., Schleicer, A., Wingert, F., Zilles, K., Loblich, H. (1979). Human
brain growth in the 19th and 20th century. Journal of the Neurological Sciences,
40, (2-3), pl69-188.

Krob, G., Braun, A., Kuhnle, U. (1994) True hermaphroditism: geographical
distribution, clinical findings, chromosomes and gonadal histology. European
Journal ofPaediatrics, 153, p2-10.

Kruijver, F, Zhou, J., Pool, C., Hofman, M, Gooren, L., Swaab, D. (2000), Male-toFemale Transsexuals Have Female Neuron Numbers in a Limbic Nucleus.
Journal of Clinical Endocrinology and Metabolism, 85, (5), p2034-2041.

Lane, A., Donahoe, P. (1998). New insights into Mullerian inhibiting substance and
its mechanism of action. Journal ofEndocrinology, 158, pl-6.

Larsen, W. (2001). Human Embryology (3rd Edition). Churchill Livingstone: London.

Lasco, M., Jordan, T., Edgar, M., Petito, C., Byne, W. (2002). A lack of dimorphism
of sex or sexual orientation in the human anterior commissure. Brain
Research, 936, p95-98.

Le, W., Rowe, D., Jankovic, J., Xie, W., Appel, S. (1999). Effects of cerebrospinal
fluid from patients with Parkinson's disease on dopaminergic cells. Archives
ofNeurology, 56, p194-200.

Legget, M., Kuusisto, J., Healy, N., Fujioka, M., Schwaegler, R., Otto, C. (1996).
Gender differences in left ventricular function at rest and with exercise on
asymptomatic aortic stenosis. American Heart Journal, 131, 94-100.

Lei, N., Heckert, L. (2004). Gata4 Regulates Testis Expression ofDmrtl. Molecular
and Cellular Biology, 24, (1), p377-388.

Leinwand, L. (2003). Sex is a potent modifier of the cardiovascular system. Journal of
Clinical Investigation, 112, (3), p302-307.
78

Madeira, M., Leal, S., Paula-Barbosa, M. (1999). Stereological evaluation and Golgi
study of the sexual dimorphisms in the volume, cell numbers, and cell size in
the medial preoptic nucleus of the rat. Journal of Neurocytology, 28, pl31148.

Manson, J., Martin, K. (2001). Post-menopausal hormone-replacement therapy. New
England Journal of Medicine, 345, p34-40.

Marieb, E., Hoehn, K. (2006). Human Anatomy and Physiology (7th ed). USA:
Prentice-Hall Inc.

Martini, F. (2005). Fundamentals of Anatomy and Physiology (7th ed). USA:
Prentice-Hall Inc.

Mendelsohn, M., Karas, R. (2005). Molecular and cellular basis of cardiovascular
gender differences. Science, 308, pl583-1587.

Mendonca, B., Inacio, M., Arnhold, I., Costa, E., Bloise, W., Martin, R., Denes, I.,
Silva,

F.,

Andersson,

S.,

Lindqvist,

A.,

Wilson,

J.

(2000).

Male

pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3
deficiency. Diagnosis, psychological evaluation, and management. Medicine
(Baltimore), 19, (5), p299-309.

Merke, D., Bomstein, S. (2006). Congenital adrenal hyperplasia. Lancet, 365,
p2125-2136.

Milanov, I., Kmetska, K., Karakolev, B., Nedialkov, E. (2001). Prevalence of
Parkinson's disease in Bulgaria. Neuroepidemiology, 20, p212-214.

Moir, A., Jessel, D. (1991). Brain Sex: the Real Difference Between Men and
Women. London: Arrow Books.

Morrish,C., Sinclair, A. (2002). Vertebrate sex determination: many means to an end.
Reproduction, 124, p447-457.
79

Mufson, E., Cai, W., Jaffer, S., Chen, E., Stebbins, G., Sendera, T., Kordower, J.
(1999). Estrogen receptor immunoreactivity within subregions of the rat
forebrain: Neuronal distribution and association with perikarya containing
choline acetyltransferase. Brain Research, 849, p253-274.

Nachitigalm, M., Hirokawa, Y., Enyeart-VanHouten, D., Flanagan, J., Hammer, G.,
Ingraham, H. (1998). Wilms' tumor 1 and Dax-1 modulate the orphan nuclear
receptor SF-I in sex-specific gene expression. Cell, 93, p445-454.

Nagatsu, T., Mogi, M., Ichinose, H., Togari, A. (2000). Cytokines in Parkinson's
/

disease. Journal ofNeural Transmission Supplement, 58, p143-151.

Nagatsu, T. (2002). Parkinson's disease: changes in apoptosis-related factors
suggesting possible gene therapy. Journal ofNeural Transmission, 109, p731745.

Narr, K., Thompson, P., Sharma, T., Moussau, J., Cannestra, A., Toga, A. (2000).
Mapping Morphology of the Corpus Callosum in Schizophrenia. Cerebral
Cortex, 10, p40-49.

Nelson, C., Gearhart, J. (2004). Current views on evaluation, management, and
gender assignment of the intersex infant. Nature Clinical Practice Urology, 1,
(1), p38-43.

New, M. (1998). Diagnosis and Management of Congenital Adrenal Hyperplasia.
Annual review of Medicine, 49, p311-328

Nopoulos, P., Flaum, M., Andreasen, N. (1997). Sex Differences in Brain
Morphology in Schizophrenia. American Journal of Psychiatry, 154, (12),
pl648-1654.

Olsen, N., Kovasc, W. (2002). Hormones, pregnancy and rheumatoid mihritis.
Journal of Gender Specific Medicine, 5, (4), p28-37.

80

Osman, M. (2003). Therapeutic implications of sex differences in asthma and atopy.
Archives of Disease in Childhood, 88, (7), p587-591.

Ott, B., Cahn-Weiner, D. (2001). Gender Differences in Alzheimer's Disease.
Geriatric Times, II, (6), p 598-605.

Pinn, V. (2003). Sex and Gender Factors in Medical Studies: Implications for Health
and Clinical Practice. Journal of American Medical Association, 289, (4),
p397-400.
Powell, K. (2004). Opening a Window to the Autistic Brain. PLoS Biology, 2, (8),
p1054-1058

Qin, Y., Bishop, C. (2005). Sox9 is sufficient for functional testis development
producing fertile male mice in the absence of Sry. Human Molecular Genetics,
14, (9), p 1221-1229.

Queipo, G., Zenteno, J., Pena, R., Nieto, K., Radillo, A., Dorantes, L., Erana, L.,
Lieberman, E., Soderlund, D., Jimenez, A., Ramon, G., Kofman-Alfaro, S.
(2002). Molecular analysis in true hermaphroditism: demonstration of low
level hidden mosaicism for Y -derived sequences in 46, XX cases. Human
Genetics, 111, p278-283.

Rabinowicz, T., Dean, E., Petetot, J., de Courten-Myers, G. (1998). Gender
differences in the human cerebral cortex: More neurons in males; more
processes in females. Journal of Child Neurology, 13, (in press).

Rabinowicz, T, MacDonald-Comber Petetot, J., Gartside, P., Sheyn, D., de CourtenMyers, G. (2002). Structure of the Cerebral Cortex in Men and Women.
Journal ofNeuropathy and Experimental Neurology, 61, (1), p46-57.

Rasia-Filho, A., Londero, R., Achaval, M. (2000). Functional activities of the
amygdala: an overview. Journal ofPsychiatly and Neuroscience, 25, (1), p1423.

81

Regadera, J., Martinez-Garcia, F., Paniagua, R. and Nistal, M. (1999). Androgen
Insensitivity

Syndrome:

an

Immunohistochemical,

Ultrastructural

and

Morphogenic Study. Archives of Pathology and Laboratory Medicine, 123,
(3), p225- 234.

Rehman, K., Carr, B. (2004). Sex differences in adrenal androgens. Seminars in
Reproductive Medicine, 22, (4), p349-360.

Reiss, A., Abrams, M., Singer, H., Ross, J., Denckla, M. (1996). Brain development,
gender and IQ in children. Brain, 119, p1763-1774.

Rieker, P., Bird, C. (2005). Rethinking Gender Differences in Health: Why We Need
to Integrate Social and Biological Perspectives. Journals of Gerontology, 60B,
(Special Issue II), p40-4 7.

Rogers, A., Eastell, R. (2001). The effect of 17beta-estradiol on production of
cytokines in cultures of peripheral blood. Bone, 29, p30-34.

Rubin, E. (2001). Essential Pathology (3rd ed). USA: Lippincott Williams and
Wilkins.

Salas-Cortes, L., Jaubert, F., Nihoul-Fekete, C., Brauner, R., Rosemblatt, M., Fellous,
M. (2000). S1y protein is expressed in ovotestis and streak gonads from human
sex-reversal. Cytogenetics and Cell Genetics, 91, p212-216.

Schumann, C., Hamstra, J., Goodlin-Janes, B., Lotspeich, L., Kwon, H., Buonocore,
M., Lammers, C., Reiss, A., Amaral, D. (2004). The amygdala is Enlarged in
Children But Not Adolescents with Autism; the Hippocampus is Enlarged at
All Ages. The Journal ofNeuroscience, 24, (28), p6392-6401.

Smith, R. (2005). Relative Size versus Controlling for Size: Interpretation of ratios
in research on sexual dimorphism on the Human Corpus Callosum. Current
Anthropology, 46, (2), p249-279.

82

Sommer, I., Aleman, A., Bouma, A., Kahn, R. (2004). Do women really have more
bilateral language representation than men? A meta-analysis of functional
imaging studies. Brain, 127, (8), p1845-1852.

Spires, T., Hyman, B. (2005). Transgenic models of Alzheimer's Disease: Learning
from Animals. The Journal of the American Society for Experimental
NeuroTherapeutics, 2, (3), p423-437.

Stone, J., Merriman, B., Cantor, R., Yonan, A., Gilliam, T., Geschwind, D., Nelson,
S. (2004). Evidence for Sex-Specific Risk Alleles in Autism Spectrum
Disorder. American Journal of Human Genetics, 75, p1117-1123.

Stromberg, A., Martensson, J. (2003). Gender differences in patients with heart
failure. European Journal of Cardiovascular Nursing, 2, p7 -18.

Sumner, B., Grant, K., Rosie, R., Hegele-Hartung, C., Fritzmeier, K., Fink, G. (1999).
Effects of tamoxifen on serotonine transporter and 5-hydroxytryptamine2A
receptor binding sites and mRNA levels in the brain of ovariectomized rats
with or without estradiol replacement. Molecular Brain Research, 73, p119128.

Swaab, D. (1995). Development of the human hypothalamus. Neurochemical
Research, 20, p509-519.

Swaab, D., Chung, W., Kruijver, F., Hofman, M., Hestiantoro, A. (2003). Sex
differences in the hypothalamus in the different stages of human life.
Neurobiology of Ageing, 24, Sl-S16.

Swaab, D., Gooren, L., Hofman, M. (1992). Gender and sexual orientation in relation
to hypothalamic structures. Hormone Research, 38, (S2), p51-61.

Swaab, D and Hofman, M. (1995). Sexual differentiation of the human hypothalamus
in relation to gender and sexual orientation. Trends in Neuroscience, 18, (6),
p264- 270.
83

Swain, A., Lovell-Badge, R. (1999). Mammalian sex determination: a molecular
drama. Genes and Development, 19 (7), p755-767.

Szelenyi, J. (2001). Cytokines and the nervous system. Brain Research Bulletin, 5,
p329-338.

Takahashi, S., Matsuura, M., Tanabe, E., Yara, K., Nonake, K., Fukara, Y., Kikuchi,
M., Kojima, T. (2000). Age at onset of schizophrenia: Gender differences and
influence of temporal socioeconomic change. Psychiatry and Clinical
Sciences, 54, p153-156.

Thompson, T., Caruso, M., Ellerbeck, K. (2003). Sex matters in autism and other
developmental disabilities. Joumal ofLeaming Disabilities, 7, (4), p345-362.

Tizard, I. (1995). Immunology: an Introduction (4th ed). USA: Saunders College
Publishing.

Tranel, D., Damasio, H., Denburg, N., Bechara, A. Does gender play a role in
functional asymmetry of ventromedial prefrontal cortex?. Brain, 128, p28722881.

Vaccarino, V., Parsons, L., Every, N., Banon, H., Krumholz, H. (2000). Impact of
history of diabetes mellitus on hospital mortality in men and women with first
acute myocardial infarction. American Joumal of Cardiology, 85, p1486-1489.
Val, P., Lefrancois-Martinez, A., Veyssiere, G., Martinez, A. (2003). SF-1 a key
player in the development and differentiation of steroidogenic tissues. Nuclear
Receptor, 1, (1), p 8 -31.

Van Den Eeden, S., Tanner, C., Bemstein, A., Fross, R., Leimpeter, A., Bloch, D.,
Nelson, L. (2003). Incidence of Parkinson's Disease: Variation by Age,
Gender, and Race/Ethnicity. American Joumal of Epidemiology, 157, (11),
p1015-1022.

84

Viger, R., Silversides, D., Tremblay, J. (2005). New Insights into the Regulation of
Mammalian Sex Determination and Male Sex Differentiation. Vitamins and
Hormones, 70, p387-413.

Von Esenwein, Silke, A. (2005). Sexual differentiation of two hypothalamic nuclei
in the rat: Anatomical, behavioural, and genomic consequences of a single
exposure to testosterone during perinatal development. Emory University.

Walker, Q., Rooney, M., Wightman, R., Kuhn, C. (2000). Dopamine release and
uptake are greater in female than male rat striatum as measured by cyclic
voltammetry. Neuroscience, 95, p1061-1070.

Wasef, Y. (2004). Gender Differences in Systemic Lupus Erythematosus.
Gender Medicine, 1, (1), p12-17.

Watanabe, Koji., Clarke, T., Lane, A., Wang, X., Donahoe, P. (2000). Endogenous
expression of Mullerian inhibiting substance in early postnatal rat Sertoli cells
requires multiple

steroidogenic factor-1

and GATA-4 binding sites.

Proceedings of the National Academy of Sciences of the United States of
America, 97 (4), p1624-1629.

WebPath. (2006). The Internet pathology Laboratory for Medicine. Florida State
University. Retrieved October 18, 2006, from
http://www-medlib.med. utah.edu/WebPath/CNSHTML/CNS 102.html

Wigal, S., Swanson, J., Potkin, S. (1997). Lateralised attention deficits in drug-free
and medicated schizophrenia patients. Neuropsychologia, 35, p1519-1525.

Wilder, R. (1996). Adrenal and gonadal steroid hormone deficiency in the
pathogenesis of rheumatoid arthritis. Journal of Rheumatology Supplement,
44, (10), p10-12.

Witchel, S. (2002). Hyperandrogenism in adolescents. Adolescent Medicine, 13 (1),
p89-99.
85

Witelson. S., Beresh, H., Kigar, D. (2006). Intelligence and brain size in 100 postmortem brains: sex, lateralisation and age factors. Brain, 129, p386-398.

Wizemann, T., Pardue, M, eds. (2001). Exploring the Biological Contributions to
Human Health: Does Sex Matter?. Washington DC: National academy Press.

Wright, I., Rabe-Hesketh, S., Woodruff, P., David, A., Murray, R., Bullmore, E.
(2000). Meta-Analysis of Regional Brain Volumes in Schizophrenia. The
American Journal of Psychiatry, 157, (1), p16-25.

Yue, X., Lu, M., Lancaster, T., Cao, P., Honda, S., Staufenbiel, M., Harada, N.,
Zhong, Z., Shen, Y., Li, R. (2005). Brain estrogen deficiency accelerates AB
plaque formation in an Alzheimer's disease animal model. Proceedings of the
National Academy of Sciences of the United States of America, 102, (52), p
19198-19203

Zazopoulos, E., Lalli, E., Stocco, D., Sassone-Corsi, P. (1997). DNA binding and
transcriptional repression by DAX-1 blocks steroidogenesis. Nature, 390,
p311-315.

86

